Role of adenosine A₂A receptor in pressure-induced retinal microglia reactivity by Aires, Inês Sofia Dinis
Inês Soa Dinis Aires
Junho de 2014
ROLE OF ADENOSINE A2A RECEPTOR IN 
PRESSURE-INDUCED RETINAL MICROGLIA REACTIVITY
Dissertação para a obtenção do grau de Mestre em Investigação Biomédica sob orientação cientíca da Doutora Ana 
Raquel Sarabando Santiago e co-orientação do Doutor António Francisco Rosa Gomes Ambrósio e apresentada à 
Faculdade de Medicina da Universidade de Coimbra.
  
  
  
“O entusiasmo é a maior força da alma. Conserva-o e nunca te faltará poder para  
conseguires o que desejas.” 
Napoleão Bonaparte 
On the front page: 
Microglia cell (BV-2) stained with phalloidin (red) with e gulfed beads (gr en),
Nuclear staining blue (DAPI). 
  
  
 
Role of adenosine A2A receptor in pressure-
induced retinal microglia reactivity 
 
 
Inês Sofia Dinis Aires 
 
 
 
Dissertação apresentada à Faculdade de Medicina da Universidade de Coimbra para 
cumprimento dos requisitos necessários à obtenção do grau de Mestre em Investigação 
Biomédica. Este trabalho foi realizado no Centro de Oftalmologia e Ciências da Visão, no 
Instituto de Imagem Biomédica e Ciências da Vida (IBILI) da Faculdade de Medicina da 
Universidade de Coimbra, sob a orientação científica da Doutora Ana Raquel Sarabando 
Santiago e supervisão do Doutor António Francisco Rosa Gomes Ambrósio. 
 
 
 
 
Universidade de Coimbra 
2014 
  

   
Este trabalho foi em parte financiado por: Fundação para a Ciência e Tecnologia (FCT) 
e FEDER. FCT (PTDC/BIM-MEC/0913/2012); FCT projecto estratégico (PEst-
C/SAU/LA0001/2013-2014). 
 
  
  
  
“O entusiasmo é a maior força da alma. Conserva-o e nunca te faltará poder 
para conseguires o que desejas.”  
Napoleão Bonaparte 
  
 Agradecimentos 
Esta tese é fruto do esforço e dedicação de várias pessoas que pelo apoio e disponibilidade me 
transmitiram a força e conhecimentos necessários para a superação de mais esta etapa. Estas 
palavras são dedicadas a todos os que de uma forma ou de outra contribuíram para o meu 
sucesso. 
Em primeiro lugar gostaria de agradecer à Doutora Raquel Santiago, orientadora desta tese, pela 
disponibilidade, pela atenção, por todos os ensinamentos e repreensões que me fizeram 
aprender, integrar e crescer no mundo da ciência. Tenho de reconhecer todo o esforço e apoio 
prestado, muitas vezes até de madrugada para que “uma das suas meninas” alcançasse o tão 
desejado objectivo. Foi difícil, ambas sabemos! Muitas tardes de desespero a olhar para retinas 
KO ou, possivelmente, não KO e, toda uma descoberta que iniciamos juntas no maravilhoso 
desconhecido mundo dos explantes de ratinho. (ahh! E não pudemos esquecer as tardes de 
hipóxia momentânea aquando da montagem dos mesmos!) 
Gostaria também de agradecer ao Doutor Francisco Ambrósio, co-orientador desta tese por, 
prontamente, me ter acolhido no seu laboratório e me ter apoiado, integrado e proporcionado 
todas as condições para a realização desta tese. Acima de tudo agradeço pela confiança que 
depositou em mim que muito me motivou na conclusão deste trabalho.   
Agradeço também à Doutora Carla Marques por me ter ajudado nas dificuldades e angústias 
que me foram acompanhando ao longo do ano e, por ter sempre tido um conselho e uma 
palavra amiga para dar no momento certo. 
Não posso deixar de agradecer também à Professora Doutora Manuela Grazina por ter 
autorizado a utilização do Real-Time-PCR e à Maria João pela paciência e por me ter ajudado na 
obtenção dos resultados. 
Gostaria também de agradecer à Joana Vindeirinho que muito me ajudou na técnica de HPLC e 
ao Francisco Queiróz pelo apoio prestado na quantificação de ATP. 
Como não poderia deixar de ser tenho de deixar um obrigado a todos os meus colegas de 
trabalho à Joana, à Marlene, à Catarina, à Sónia, à Elisa, ao Dan, por me terem ensinado e 
acompanhado durante este longo percurso.  
Gostaria de deixar um especial agradecimento: 
À Sandra por termos começado juntas e, desde sempre, me teres motivado e incentivado a ser 
melhor sendo um grande exemplo de luta e perseverança. 
Ao João por todos os “Tá tudo mal! Isso tá tudo contaminado! Tá tudo mal!” sempre com boa 
disposição a incentivar o aumento da minha confiança no trabalho do dia-a-dia e, também por 
toda a disponibilidade e companhia para revestimentos de caixas de cultura em fins-de-semana 
solitários.  
À Filipa por todas as palavras de amizade toda a calma e alegria que me transmitiste ao longo 
dos intensos dias de trabalho. Teria sido mais difícil sem a tua sensatez e tranquilidade. 
À Maria por ter sido a minha companheira nas lutas para fechar a nossa velhinha câmara de 
pressão, por me ter ensinado quando eu ainda nada sabia e, por me ter apoiado ao longo deste 
ano, sendo a primeira menina do “A2AR team”. 
À Tânia quero agradecer pela espontaneidade, por me ter aturado a mim e ao Gato no dia-a-dia 
durante os últimos meses desta etapa, por todas as conversas de fim de tarde, pela companhia e 
pela amizade. 
Ao Gato quero agradecer toda a companhia que me fez durante a escrita desta tese porque sem 
as tuas travessuras os meus dias teriam sindo mais difíceis. 
À Raquel tenho de agradecer toda a disponibilidade, carinho e dedicação que demostraste pelo 
teu, pelo meu e pelo trabalho de todos no lab, nunca deixaste ninguém desamparado, estando 
sempre disponível para ajudar e apoiar. Quero agradecer-te toda a ajuda que me deste desde o 
primeiro momento, ficando até ser noite no lab, discutindo possíveis resultados e problemas bem 
como procurando lado a lado comigo todas as soluções para as meninas do A2AR team. 
Obrigada também pelas conversas motivadoras em todos os momentos em que a chorar te disse 
“não vou conseguir, é impossível”, e tu tinhas razão a tese está pronta porque “se os outros 
conseguem tu também consegues!”. 
Às amigas de sempre à Rita, à Sara, à Inês, à Carina pela paciência quando não podia 
encontrar-vos para tomar café porque tinha células à minha espera, por todos os telefonemas e 
conversas de motivação e desespero, por todas as saídas e jantares que se concretizaram e 
acabaram sempre com muitos sorrisos, uns pés doridos e farinha aqui e ali. Por serem as amigas 
de sempre que por mais que o espaço e a falta de tempo afastem, vão estar sempre lá! 
Obrigado! 
 Ao Sérgio quero agradecer todo o carinho, toda a paciência e momentos de cumplicidade que 
me fizeram lembrar que a vida não é só a ciência. Ainda me lembro do dia em que foste comigo 
ao lab e viste células ao microscópio pela primeira vez, estavas radiante! Foi um orgulho mostrar-
te de perto o meu trabalho fazer-te perceber o porquê de passar tantas horas fechada naquele 
edifício amarelo mal iluminado, a paixão pela ciência é algo que me move e tu percebeste isso aí 
e a nossa ligação ficou mais forte de dia para dia!   
Agradeço aos meus avôs por todo o carinho e preocupação, porque mesmo sem entenderem o 
que é uma célula fazerem sempre um esforço para me ouvir e apoiar o meu estudo, motivando-
me para dar o meu melhor. Agradeço especialmente às minhas avós, à avó Maria porque me 
criou, me acarinha e apoia incondicionalmente e à minha avó Helena por ser uma estrelinha no 
céu a iluminar o meu caminho e me acompanhar todos os dias. 
Agradeço ao meu maninho por ser o meu melhor amigo, o companheiro de sempre e pelo 
abraço bem forte na altura certa, quando o meu mundo desaba tu estás sempre lá para me 
levantar com uma palavra sábia de carinho e tranquilidade. Sei que sou o teu orgulho e tu és o 
meu exemplo, o meu Pepas, nunca te vou desiludir, quero fazer mais e melhor para ser como tu! 
Acima de tudo gostaria de agradecer aos meus pais por me terem proporcionado este momento, 
por me terem educado, amado e apoiado nas minhas escolhas por mais que fossem difíceis de 
entender. Por terem sido sempre o meu abrigo e a minha motivação para ser melhor, por serem 
dois grandes exemplos de humildade, força e perseverança e porque nada seria sem vocês, 
obrigado!
  
Contents 
 
 
I 
Contents 
Abbreviations_______________________________________________________________ V 
Resumo ___________________________________________________________________ ix 
Abstract __________________________________________________________________ xi 
1. Introduction ______________________________________________________________ 3 
1.1. Vision __________________________________________________________________ 3 
1.2. Anatomy of the eye _____________________________________________________ 3 
1.3. Retina __________________________________________________________________ 4 
1.3.1. Neurons _______________________________________________________________ 6 
1.3.1.1. Photoreceptors ______________________________________________________ 6 
1.3.1.2. Bipolar cells _________________________________________________________ 6 
1.3.1.3. Retinal ganglion cells ___________________________________________________ 7 
1.3.1.4. Horizontal cells ______________________________________________________ 7 
1.3.1.5. Amacrine cells _______________________________________________________ 7 
1.3.2. Visual pathways __________________________________________________________ 7 
1.3.3. Blood vessels ___________________________________________________________ 8 
1.3.4. Glial cells of the retina _____________________________________________________ 9 
1.3.4.1. Müller cells _________________________________________________________ 9 
1.3.4.2. Astrocytes __________________________________________________________ 9 
1.3.4.3. Microglia __________________________________________________________ 10 
1.3.4.3.1. Retinal microglia _________________________________________________ 11 
1.4. Glaucoma _____________________________________________________________ 12 
1.4.1. Glaucoma and neuroinflammation ___________________________________________ 13 
1.5. Adenosine _____________________________________________________________ 13 
1.5.1. Adenosine receptors _____________________________________________________ 14 
1.5.1.1. A1 receptors ________________________________________________________ 16 
1.5.1.2. A2A receptors _______________________________________________________ 16 
1.5.1.3. A2B receptors _______________________________________________________ 17 
1.5.1.4. A3 receptors _______________________________________________________ 17 
1.6. Neuroprotection mediated by A2AR ______________________________________ 18 
1.7. Elevated hydrostatic pressure model _____________________________________ 18 
Aims ______________________________________________________________________ 20 
2. Methods ________________________________________________________________ 25 
2.1. Animals _______________________________________________________________ 25 
2.2. Mice genotyping _______________________________________________________ 25 
2.3. Primary retinal neural cell cultures ______________________________________ 26 
2.4. BV-2 cell line __________________________________________________________ 26 
2.5. Retinal explants ________________________________________________________ 27 
2.6. Cell treatment _________________________________________________________ 27 
2.7. Immunocytochemistry _________________________________________________ 28 
Contents 
 
 
II 
2.7.1. Cell cultures ___________________________________________________________ 28 
 ________________________________________________________________________ 29 
2.7.2. Organotypic retinal cell cultures ____________________________________________ 29 
2.8. Densitometric analysis of iNOS immunoreactivity ________________________ 29 
2.9. Reactive oxygen species quantification by dihydroethidium staining ________ 30 
2.10. Nitrite quantification assay ____________________________________________ 30 
2.11. Assessment of cell morphology ________________________________________ 30 
2.12. Cell proliferation assay ________________________________________________ 31 
2.13. Terminal deoxynucleotidyl transferase (TdT)-mediated dUTP nick end 
labeling (TUNEL) assay ____________________________________________________ 31 
2.14. Phagocytosis assay ____________________________________________________ 31 
2.15. Scratch wound assay __________________________________________________ 32 
2.16. Boyden chamber migration assay ______________________________________ 32 
2.17. Determination of adenosine concentration by high performance liquid 
chromatography ___________________________________________________________ 33 
2.18. Determination of ATP concentration by luciferin-luciferase bioluminescence 
assay _____________________________________________________________________ 34 
2.19. RNA extraction _______________________________________________________ 34 
2.20. Reverse transcription _________________________________________________ 35 
2.21. Real-time quantitative PCR ____________________________________________ 36 
2.22. Quantification of pro-inflammatory cytokines ___________________________ 36 
2.23. Preparation of frozen retinal sections ___________________________________ 37 
2.24. Assessment of retinal structure ________________________________________ 38 
2.25. Statistical analysis ____________________________________________________ 38 
3. Results _________________________________________________________________ 41 
3.1. Effect of elevated hydrostatic pressure in the expression of A2AR in primary 
retinal neural cell cultures __________________________________________________ 41 
3.2. Elevated hydrostatic pressure increases oxidative/nitrosative stress in primary 
retinal cultures ____________________________________________________________ 42 
3.3. Effect of elevated hydrostatic pressure in the expression and release of TNF 
and IL-1β in primary mixed retinal neural cell cultures ________________________ 44 
3.4. Effect of A2AR blockade cell death induced by elevated hydrostatic pressure in 
retinal neural cell cultures __________________________________________________ 45 
3.5. Elevated hydrostatic pressure changes microglia morphology ______________ 47 
3.6. Elevated hydrostatic pressure increases the number of microglia in primary 
mixed retinal neural cell cultures____________________________________________ 49 
Contents 
 
 
III 
3.7. Effect of elevated hydrostatic pressure on the levels of pro-inflammatory 
cytokines in BV-2 cells ______________________________________________________ 51 
3.8. Elevated hydrostatic pressure increases BV-2 cell motility _________________ 51 
3.9. Effect of elevated hydrostatic pressure on the extracellular levels of ATP and 
adenosine _________________________________________________________________ 53 
3.10. Phagocytosis increases upon elevated hydrostatic pressure in BV-2 cells and is 
prevented by the blockade of A2AR __________________________________________ 54 
3.11. Effect of elevated hydrostatic pressure on the morphology of microglia in 
retinal organotypic cultures _________________________________________________ 55 
4. Discussion _______________________________________________________________ 61 
5. Concluding remarks and future perspectives _______________________________ 69 
6. References ______________________________________________________________ 73 
 
  
Abbreviations 
 
 
V 
Abbreviations 
A1R A1 receptor  
A2AR A2A receptor  
A2BR A2B receptor  
A3R A3 receptor  
AC Adenylyl cyclase 
ADA Adenosine deaminase 
ADP Adenosine diphosphate 
AK Adenosine kinase  
AMP Adenosine monophosphate 
AR Adenosine Receptors 
ATP Adenosine triphosphate 
BCA Bicinchoninic acid  
BRB Blood-retinal barrier 
BSA Bovine Serum Albumin  
cAMP Cyclic adenosine monophosphate 
CD11b Cluster of differentiation molecule 11B  
CNS Central nervous system 
CNTs Concentrative nucleoside transporters  
CREB cAMP responsive element binding protein  
CTCF Corrected total cell fluorescence  
CTZ Cyclothiazide 
Cyt-5'-NT Cytosolic-5'-nucleotidase 
DAPI 4',6-diamidino-2-phenylindole  
DHE Dihydroethidium 
Dnase I Deoxyribonuclease I 
Ecto-5’NT Ecto-5'-nucleotidase 
EdU 5-ethynyl-2´-deoxyuridine 
Abbreviations 
 
VI 
EHP Elevated Hydrostatic Pressure 
ELISA Enzyme-linked immunosorbent assay 
ENTs Equilibrative bi-directional nucleoside transporters 
FBS Fetal bovine serum 
G proteins GTP-binding proteins 
GCL Ganglion cell layer 
GFAP Glial fibrillary acidic protein   
Gi/o Inhibitory G-protein 
Gs Stimulatory G-protein 
HBSS Hank's balanced salt solution 
Hcy Homocysteine 
HPLC High performance liquid chromatography  
Iba-1 Ionized calcium-binding adapter molecule 1 
iBRB Inner blood-retinal barrier  
IL Interleukin 
INL Inner nuclear layer  
iNOS   Inducible nitric-oxide synthase 
IOP Intraocular pressure  
IPL Inner plexiform layer  
KA Kainate 
LPS Lipopolysaccharide 
MAP Mitogen-activated protein  
MEM Eagle’s minimum essential medium   
NFL Nerve fiber layer  
NO Nitric oxide 
oBRB Outer blood-retinal barrier 
ONL Outer nuclear layer 
OPL Outer plexiform layer 
Abbreviations 
 
 
VII 
OS/IS Outer and inner segments  
PBS Phosphate-buffered saline  
PFA Paraformaldehyde 
PI3 phosphoinositide 3  
PIO Pressão intra-ocular 
PKA Protein kinase A  
PKC Protein kinase C  
RGC Retinal ganglion cell 
ROS Reactive Oxygen Species 
RPE Retinal pigment epithelium 
RPMI Roswell Park Memorial Institute medium 
rTdT Recombinant Terminal Deoxynucleotidyl Transferase  
SAH S-adenosyl- homocysteine  
SDS Sodium dodecyl sulfate 
TE Tris EDTA 
TLR4 Toll-like receptor 4  
TLRs Toll-like receptors  
TNF Tumor necrosis factor 
TRIC Tetramethylrhodamine B isothiocyanate 
TUNEL Terminal deoxynucleotidyl transferase dUTP nick end labeling 
 
  
VIII 
 
 
Resumo 
 
ix 
Resumo 
 
O glaucoma é uma doença neurodegenerativa caracterizada pela morte das células 
ganglionares de retina e atrofia do nervo óptico, sendo a segunda principal causa de 
cegueira a nível mundial. O aumento da pressão intra-ocular (PIO) é o principal fator de 
risco para o desenvolvimento desta doença. As atuais opções terapêuticas focam-se na 
diminuição da PIO, mas apesar do controlo da PIO a doença continua a progredir 
conduzindo à morte das células ganglionares da retina. Assim sendo, novas abordagens 
terapêuticas devem ser desenvolvidas para proteger as células ganglionares da retina 
deforma atenuar a progressão da doença. A neuroinflamação parece desempenhar um 
papel crucial no desenvolvimento da doença. A ativação das células da microglia e o 
aumento da produção de mediadores pro-inflamatórios foram descritos em modelos 
experimentais de glaucoma e em doentes, o que pode contribuir para o processo 
neurodegenerativo. 
A adenosina é um neuromodulador do sistema nervoso central exercendo os seus 
efeitos através de quatro receptores, A1, A2A, A2B, A3. O bloqueio dos recetores A2A 
confere neuroprotecção em diversos modelos de doenças neurodegenerativas como a 
isquémia cerebral, as doenças de Parkinson, Alzheimer e Huntington. No cérebro, o 
bloqueio do recetor A2A previne a ativação das células da microglia, e os antagonistas do 
recetor A2A têm sido propostos como potenciais candidatos para tratamento de doenças 
neurodegenerativas em que a neuroinflamação está presente.  
Neste estudo pretendemos avaliar os efeitos do aumento da pressão hidrostática na 
reatividade das células da microglia e analisar o efeito do bloqueio dos recetores A2A na 
prevenção da ativação da microglia desencadeada pelo aumento da pressão hidrostática 
em culturas primárias de retina, na linha celular de microglia (BV-2) e em culturas 
organotípicas de retina. 
A pressão hidrostática elevada, em culturas primárias de retina, levou a um aumento 
na produção de espécies reactivas de oxigénio, libertação de citoquinas pro-inflamatórias 
e morte celular. Além disso, a exposição a pressão elevada desencadeou alterações na 
morfologia da microglia bem como na sua resposta fagocítica, proliferação e migração, 
avaliadas nos diferentes modelos celulares. 
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O bloqueio do recetor A2A diminuiu o stress oxidativo e preveniu as alterações na 
morfologia, proliferação, migração e fagocitose induzidas pelo aumento da pressão 
hidrostática. 
O aumento da pressão hidrostática conduziu a um aumento dos níveis extracelulares 
de ATP e de adenosina, o que suporta o papel da adenosina e do receptor A2A na 
resposta da microglia à exposição à pressão hidrostática aumentada.  
Em síntese, os resultados obtidos mostraram que o bloqueio do recetor A2A 
controlou a ativação da microglia prevenindo a morte das células da retina, o que sugere 
que os antagonistas dos A2AR podem ter efeitos benéficos no tratamento do glaucoma. 
 
Palavras-chave: Célula da microglia, glaucoma, neuroinflamação, neuroprotecção, 
pressão hidrostática elevada, recetores A2A de adenosina, retina. 
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Abstract 
 
Glaucoma is the second leading cause of blindness worldwide being elevated 
intraocular pressure (IOP) the main risk factor for the onset and progression of the 
disease. Glaucoma is a neurodegenerative disease characterized by retinal ganglion cell 
(RGC) loss and optic nerve atrophy. Currently, the therapeutic strategies to treat 
glaucoma patients are focused on IOP control. However, and despite IOP control, in 
some patients disease still progresses and patients continue to lose vision. Therefore in 
addition to lowering IOP, new approaches need to be developed aiming the protection of 
RGCs. Neuroinflammation may contribute to the onset and progression of glaucomatous 
disease. Activated microglia have been found in patients and experimental glaucoma 
models, playing a key role in perpetuating the inflammatory milieu by releasing pro-
inflammatory mediators, contributing for the neurodegenerative process.  
Adenosine is a neuromodulator in the central nervous system acting through four G 
coupled receptors, A1, A2A, A2B, A3. The blockade of A2AR confers protection in several 
models of neurodegenerative disorders such as brain ischemia Parkinson’s, Alzheimer’s 
and Huntington’s diseases. Probably through the control of microglia reactivity. 
Therefore, A2AR antagonists have been proposed as potential therapeutic options for the 
treatment of neurodegenerative diseases, in which neuroinflammation plays a role. 
In this study we aimed to assess the effects of elevated hydrostatic pressure (EHP) in 
the reactivity of microglia and to investigate whether A2AR blockade can prevent 
pressure-induced microglia reactivity in primary retinal neural cell cultures, in a microglial 
cell line (BV-2) and in organotypic retinal cell cultures. 
The exposure of retinal primary mixed neural cell cultures to EHP reactive oxygen 
species, cytokine release and cell death. Furthermore, EHP elicited changes in microglia 
morphology, proliferation, migration and phagocytic response, assessed in the different 
models. The blockade of the A2AR decreased oxidative stress and prevented changes in 
microglia morphology, proliferation, phagocytosis and migration induced by EHP. The 
extracellular levels of ATP and adenosine increased upon EHP, supporting a role for 
adenosine and A2AR activation in the responses of microglia during exposure to EHP. 
In summary, our results demonstrated that the blockade of the A2AR was able to 
control microglia reactivity and afforded protection to retinal cells, suggesting that A2AR 
antagonists could have beneficial effects for the treatment of glaucoma. 
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1. Introduction 
 
1.1. Vision 
The eyes are the guiders of the mind, allowing each individual to perceive the 
surroundings opening them a window to the world. In fact, is through the eyes that we 
acquire information about color, distance and shapes of our environment. In the eye, 
information conveyed by light is transformed into neuroelectrical signals that are 
promptly sent to the brain. 
 
1.2. Anatomy of the eye 
The eye is a complex optical system that presents us with a view of the surrounding 
environment. It is organized in order to accomplish two major goals: ensure the normal 
functioning and maintaining the ideal optical conditions for the access of light to the 
retina.  
 
The eye is constituted by 3 different layers: an external layer, formed by the sclera 
and cornea; an intermediate layer, distributed into two parts, the anterior (iris and ciliary 
body) and the posterior (choroid); and an internal layer, or the sensory part of the eye, 
the retina (Fig. 1). The cornea and the lens are involved in the refraction of light that is 
Figure 1 – Anatomy of the human eye (adapted from: http://www.shutterstock.com/). 
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necessary for the formation of focused images on the retina. The sclera is the supportive 
tissue of the eye conferring structure and protection to the inner tissues. The iris is a thin 
circular structure in the eye, which contains two sets of muscles with opposite actions 
functioning as the diaphragm in the cameras, allowing the iris to increase or decrease the 
pupil’s diameter, thus controlling the amount of light reaching the retina. The pigments of 
the iris confer its color. The function of the ciliary bodies is to determine the refractive 
power of the lens, allowing the formation of the image through its muscular component 
and by being attached to it by zonule fibers. The retina is the neuronal tissue of the eye 
responsible for converting the light impulse into visual signal and conveying it to the brain. 
The ocular globe is divided in 3 chambers: the anterior chamber located between the 
cornea and iris, the posterior chamber between the iris and the lens, and the vitreous 
chamber located between the lens and the retina. The anterior and posterior chambers 
are filed with aqueous humor that continuously supplies nutrients to the adjacent 
structures. Aqueous humor is continuously produced by the ciliary processes in the 
posterior chamber and flow to the anterior chamber through the pupil. The aqueous 
humor is permanently drained from the anterior chamber through a specialized 
meshwork of cells situated at the junction of the iris and the cornea (limbus). The 
vitreous chamber is filled with the vitreous humor, which represents about 80% of the 
volume of the human eye. The vitreous humor confers shape and structure to the eyeball 
and it also contains phagocytic cells that remove debris to allow a highly translucent 
medium to the retina. Adjacent to the retina is the choroid, a highly vascular layer that 
nourishes the photoreceptors (Purves and Williams, 2004). 
 
1.3. Retina 
The retina is the innermost layer of the eye, responsible for converting visual signs 
into electrical gradients that are transmitted to the brain. Indeed, the retina is part of the 
central nervous system (CNS), comprising a complex neural circuit constituted by 
neurons, glial cells and blood vessels. The light must cross all retinal layers to activate 
photoreceptors. Absorption of photons by the visual pigments of photoreceptors is 
translated into a biochemical signal, and then into an electrical signal that can stimulate 
the succeeding neurons of the retina until being transmitted to the brain via the optic 
nerve (axons of the RGCs). 
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Besides neuronal cells, the retina is also constituted by glial cells (Müller cells, 
astrocytes and microglial cells), endothelial cells and pericytes, and epithelial cells. The 
retina is highly organized being composed by alternated layers of neuronal cell bodies 
(nuclear layers) and processes (plexiform layers) (Fig. 2).  
 
The innermost layer adjacent to the vitreous is the nerve fiber layer (NFL) that is 
formed by the axons of RGCs and is followed by the GCL that contains the cell bodys of 
RGCs. The inner plexiform layer (IPL) is composed by the axon terminals of bipolar cells 
that synapse with the RGCs. The inner nuclear layer (INL) contains the nuclei of bipolar, 
horizontal, amacrine and Müller cells. The outer plexiform layer (OPL) is constituted by 
the photoreceptor axons and terminal endings that synapse with the dendrites of bipolar 
and horizontal cells. Immediately adjacent to the OPL is outer nuclear layer (ONL) 
formed by the nuclei of photoreceptors, followed by the outer and inner segments 
(OS/IS) of photoreceptors. The outermost layer of the retina is the retinal pigment 
epithelium (RPE), which is a continuous monolayer of cuboidal epithelial cells (Fig.1) (Kolb 
et al., 1995; Purves and Williams, 2004). 
Figure 2 - Retinal structure. Illustration depicting the retinal cell layers and neurons. OS/IS, outer and inner 
segments of rods and cones; ONL, outer nuclear layer; OPL, outer plexiform layer; INL, inner nuclear layer; IPL, 
inner plexiform layer; GCL, ganglion cell layer; NFL, optic nerve fiber layer. Adapted from (Kumar, 2001). 
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The RPE is the most important in normal function and support of the outer retina, 
regulating access of nutrients from the blood as well as in phagocytizing the outer 
segments of photoreceptors, and in recycling the light-sensitive pigments, essential for the 
visual cycle (Cunha-Vaz, 2004; Pournaras et al., 2008).  
 
1.3.1. Neurons 
The main function of retinal neurons is to convert the light into a neurochemical electrical 
signal and conveying it into the brain. There are five types of neurons with well-defined 
functions in the visual pathway (Kolb et al., 1995). 
1.3.1.1. Photoreceptors 
There are two types of photoreceptors in the retina: rods and cones. Both types 
have an outer segment composed of membranous disks that contain light-sensitive 
photopigment and is located next to the RPE, and an inner segment that contains the cell 
nucleus and gives rise to synaptic terminals that contact bipolar or horizontal cells (Kolb 
et al., 1995). Rods are responsible for vision at low light since they have sufficient 
sensitivity to capture the few available photons. On the other hand, cone photoreceptors 
respond selectively to photons, in normal light, in different regions of the visible spectrum 
allowing color vision (Wassle, 2004). The two types of photoreceptors are differently 
distributed across the retina. Absorption of light by the photopigment in photoreceptor 
outer segments gives rise to a cascade of events, which leads to alterations in the 
membrane potential and consequently modulates the amount of glutamate 
neurotransmitter released into the synapse (Kolb et al., 1995). 
 
1.3.1.2. Bipolar cells 
Bipolar cells transmit the synaptic input received from photoreceptors to RGCs or 
amacrine cells. Indeed, signaling from cones and rods is conducted through cone bipolar 
cells or rod bipolar cells, respectively. The human retina features roughly 10 different 
types of cone bipolar cells but only one type rod bipolar cells. Furthermore, bipolar cells 
are involved in the different visual pathways, being their interaction essential in signal 
modulation and in light adaptation (Kolb et al., 1995). 
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1.3.1.3. Retinal ganglion cells 
Retinal ganglion cells are the neurons responsible for conveying the visual signal 
originated in the photoreceptors and modulated by bipolar or amacrine cells to the brain. 
There are two different types of RGCs, the ON and the OFF cell type according to the 
pathways initiated by bipolar cells (Kolb et al., 1995). 
1.3.1.4. Horizontal cells 
The human retina has two types of horizontal cells. Both of them feed back onto the 
rod or cone photoreceptors (Kolb et al., 1995). Horizontal cells modulate signal 
transmission between photoreceptors and bipolar cells, playing an important role in its 
receptive field maintaining its sensitivity to light (Kaneda, 2013).  
 
1.3.1.5. Amacrine cells 
Amacrine cells modulate the signal transmission between bipolar cells and RGCs at 
the IPL and help to extract visual elements, such as contrast, color, brightness, and 
movement. Furthermore, amacrine cells, when excited by synaptic inputs from rod 
bipolar cells, send excitatory signals to the axon terminals of ON-cone bipolar cells via 
gap junctions and send inhibitory signals to the axon terminals of OFF-cone bipolar cells 
through synapses, modulating the signal transmission (Kaneda, 2013). 
 
1.3.2. Visual pathways  
The visual pathways can be classified in the horizontal pathway and the vertical 
pathway. The horizontal pathway, mediated by horizontal cells, modulates the interactions 
between photoreceptors and bipolar cells at OPL, and amacrine cells at INL, affecting 
bipolar and RGC communication altering the visual signal. In the vertical pathway, signals 
from photoreceptors are passed into bipolar cells which synapse directly with RGCs 
transmitting the signal. In fact, there are two parallel vertical pathways, the cone and the 
rod pathways. In the cone pathway, cones make direct synapses onto cone bipolar cells 
which in turn directly synapse with RGCs. This pathway can be further divided at level of 
bipolar cells being light responses of photoreceptors transmitted into ON- and OFF-
pathways. In the mammalian rod pathway, rods make synapses only with rod depolarizing 
bipolar cell (ON pathway) conveying the signal to the RGCs (Kolb et al., 1995).   
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1.3.3. Blood vessels 
The retina is a tissue with a high metabolism rate needing constant supply of oxygen 
and nutrients. To fulfil this metabolic request, the retina is supplied by two different 
sources of blood vessels, the central retinal artery and the choroidal blood vessels. The 
central retinal artery gives rise to capillaries responsible for nourishing the inner retina, 
while the choroidal blood vessels provide blood supply to photoreceptors in the outer 
retina (Klaassen et al., 2013).  
 
In order to allow a suitable, highly regulated, chemical environment for the 
transparent tissues of the eye, the vascular system is established by two main barrier 
structures: the blood-aqueous barrier and the blood-retinal barrier (BRB) (Cunha-Vaz et 
al., 2011). The BRB is formed by highly specialized endothelial or epithelial cells, which 
restrict the diffusion of molecules by an assembly of proteins that constitutes the 
functional tight junctions between cells (Leal et al., 2005). Moreover, the BRB can be 
divided in the inner and outer blood-retinal barriers. The inner blood-retinal barrier 
(iBRB) is established between tight junctions of endothelial cells and is complemented by 
astrocytes, Müller cells and pericytes (Fig. 3).  
Figure 3 - Illustration of the blood-retinal barrier. RPE, retinal pigment epithelium; POS, photoreceptor 
outer segments; OLM, outer limiting “membrane”; ONL, outer nuclear layer; OPL, outerplexiform layer; INL, inner 
nuclear layer; IPL, inner plexiform layer; GCL, ganglion cell layer; NFL, nerve fiber layer; ILM, inner limiting 
“membrane”, from (Hosoya and Tomi, 2008). 
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The outer blood-retinal barrier (oBRB) involves three structural entities, the 
fenestrated endothelium of the choriocapillaris, Bruch’s membrane and the RPE. 
Regarding the importance of the ocular barriers in the regulation of the eye vascular 
environment, its impairment has already been described to be related to several retinal 
diseases such as diabetic retinopathy, age-related macular degeneration, retinal vein 
occlusion, glaucoma and uveitis (Klaassen et al., 2013). 
 
1.3.4. Glial cells of the retina 
The retina has three different glial cell types: Müller cells, astrocytes and microglial 
cells. All glial cells have an important role in maintaining the homeostasis of the retinal 
tissue (Kolb et al., 1995). 
 
1.3.4.1. Müller cells 
Müller cells are the most abundant glial cells in the retina being distributed radially 
across the thickness of the retina forming architectural support structures. Furthermore, 
through the extensive ramification of their processes, Müller cells constitute an anatomic 
and functional link between neurons and blood vessels (Kolb et al., 1995). Müller cells 
modulate neuronal activity and keep homeostasis by regulating the extracellular 
concentration of potassium, which is highly increased by light stimulation, and by 
removing neurotransmitters, such as glutamate, from extracellular space following their 
release in the synaptic terminal (Newman and Reichenbach, 1996). 
 
1.3.4.2. Astrocytes 
Astrocytes are clearly distinguished by the characteristic morphology of a flattened 
cell body and a fibrous series of radiating processes being almost entirely restricted to the 
NFL. Astrocytes actively envelope RGC axons forming axonal and vascular glial sheaths, 
and are connected to blood vessels of the NFL, being part of the BRB. Furthermore, 
astrocytes also modulate retinal homeostasis by nourishing neurons with glucose and by 
regulating extracellular potassium levels and metabolism of neurotransmitters (Kolb et al., 
1995). In response to noxious stimuli, astrocytes suffer astrogliosis, a process 
Introduction 
 
10 
characterized by changes in morphology, proliferation rate and in the expression of glial 
fibrillary acidic protein (GFAP) (Hasko et al., 2005). 
 
1.3.4.3. Microglia  
Microglia are the immune competent cells of the CNS, seeking for potential threats 
and responding to alterations of the surrounding environment. Indeed, microglial cells 
constantly monitor neuronal synapses being able to detect distress signals and remove the 
impaired neurons having an important role in CNS homeostasis (Wake et al., 2009). 
Microglial cells originate from monocytic cells that migrated to the CNS during early 
development from mesodermal/mesenchymal origin (Kettenmann et al., 2011).  
In resting state, microglia are ramified and evenly distributed cells. Once they become 
activated in response to noxious stimuli, such as infection, trauma, ischemia and 
neurodegenerative disease (Bosco et al., 2011; Hasko et al., 2005), their morphology is 
altered to a more amoeboid shape with less ramifications (Kreutzberg, 1996; Lee, 2013).  
Nevertheless, microglia activation cannot be described as a transition from an OFF to an 
ON state but more like a progressive activation and deactivation state. In fact, a recent 
study Was focused on this issue, proposing that there are six stages of bidirectional 
microglial activation and deactivation (Jonas et al., 2012).  In the absence of pathological 
insults, resting microglia are far from dormant being highly dynamic, randomly extending 
and retracting their processes (Nimmerjahn et al., 2005). In the early phase of neural 
damage, microglia cells initiate repair mechanisms trying to overcome the injury. 
Although, excessive or prolonged microglia activation may lead to chronic inflammation 
with severe pathological consequences that potentially culminate in irreversible neuronal 
loss. In fact, this deleterious effect of chronic microglia activation has already been 
described as being related to onset and progression of neurodegenerative diseases such 
as Alzheimer’s and Parkinson’s diseases, and also glaucoma (Almasieh et al., 2012; 
Karlstetter et al., 2010).  
Under pathological conditions several mediators are released by injured cells as a 
distress signal, triggering microglia activation by interaction with immune receptors such 
as Toll-like receptors (TLRs), scavenger receptors, and numerous cytokine and 
chemokine receptors (Kierdorf and Prinz, 2013). Furthermore, once activated, microglial 
cells are able to produce and release pro-inflammatory mediators such as nitric oxide 
(NO), reactive oxygen species (ROS), cytokines such as tumor necrosis factor (TNF), 
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interleukin (IL)-1β, and IL-6 (Lee, 2013). Moreover, microglia release chemokines to 
attract other immune cells and secrete several polypeptide neurotrophic factors, which 
influence the physiology and survival of surrounding neurons (Kettenmann et al., 2011; 
Langmann, 2007). Additionally, microglia migrate through the tissue toward lesion areas 
following chemotactic distress signals (Davalos et al., 2005), and once in lesion site, 
microglial cells can proliferate (Gomez-Nicola et al., 2013) and dynamically clear their 
surroundings by phagocytizing debris and apoptotic cells (Petersen and Dailey, 2004). 
 
1.3.4.3.1. Retinal microglia 
In the retina, under physiological conditions microglia can be found in the NFL, GCL 
as well as within IPL or above the INL (Bosco et al., 2011). In resting states microglia are 
known to release mediators that stimulate the survival and regeneration of RGC and 
regulate the survival of photoreceptors (Langmann, 2007).  
 
 
Similar to what has been described for brain resident microglia, retinal microglia 
present alterations in active/resting state and are also involved in retinal 
Figure 4 - Schematic representation of three common phases of microglial activity in the retina. (A) 
In physiological conditions microglia mainly populate the plexiform layers of the retina, continuously scannig their 
environment, phagocytosing cell debris and secreting neurotrophins; (B) Various noxious stimuli that lead to 
abnormal cell functions rapidly alert microglia; (C) Microglia quickly migrate to the lesion site, where they transform 
into amoeboid full-blown phagocytes. RPE, retinal pigment epithelium; ONL, outer nuclear layer; OPL, outer 
plexiform layer; INL, inner nuclear layer; IPL, inner plexiform layer; GCL, ganglion cell layer (Karlstetter et al., 
2010). 
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neurodegenerative pathologies such as glaucoma, diabetic retinopathy and age-related 
macular degeneration (Gupta et al., 2003; Rungger-Brandle et al., 2000; Zeng et al., 2000).  
The presence of microglial cells in the vicinity of GCL and IPL suggests that its 
activation may be implicated in RGC impairment in retinal degenerative diseases. In 
resting state, microglia present long protrusions that continuously scan retinal 
parenchyma, phagocytize cell debris and secrete supporting factors (Fig. 4A). Noxious 
stimuli that lead to abnormal cell function or degeneration, trigger microglia activation 
(Fig. 4B), promoting cell migration to the lesion site, where they change into amoeboid 
full-blown phagocytes (Fig. 4C) (Karlstetter et al., 2010). These activated cells may have 
protective or deleterious effects depending on their immunological phenotype and the 
local cytokine milieu, as described for brain microglial cells. Recent studies reveal that 
microglia activation occurs in an early stage of retinal disease suggesting an inductive role 
of microglia response to disease progression (Lee et al., 2008). Nevertheless, the 
mechanisms underlying RGC death mediated by microglia activation in neurodegenerative 
diseases, such as glaucoma, are not yet fully understood. 
 
1.4. Glaucoma 
Glaucoma is a group of diseases characterized by progressive optic nerve atrophy 
and RGC death (Vohra et al., 2013). It is the second leading cause of irreversible 
blindness worldwide and it is expected that by the year 2020 approximately 80 million 
people will suffer from this disease (Quigley and Broman, 2006). Furthermore, changes in 
the visual field are not detected until the disease is advanced, compromising its early 
diagnostic. Visual loss in glaucoma starts at the periphery, not affecting central vision at 
first (Cohen and Pasquale, 2014). Elevated intraocular pressure (IOP) is the main risk 
factor for the development of glaucoma. Nevertheless, patients may present IOP within 
the normal range and still develop glaucoma. Advanced age has also been identified as an 
important risk factor for the development of glaucomatous disease (Almasieh et al., 2012; 
Zhang et al., 2007). Several hypotensive treatments have been developed including 
pharmacological approaches and surgical outflow procedures and laser treatment. 
However, treatments lower IOP but are not able to halt disease progression or cure the 
glaucomatous lesions (Cohen and Pasquale, 2014). 
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1.4.1. Glaucoma and neuroinflammation  
Progressive degeneration of optic nerve axons and RGCs in human glaucoma is 
accompanied by alterations in structural and functional characteristics in the glial cells of 
the retina (Tezel, 2011). Neuronal degeneration in glaucoma might be due to a 
combination of molecular factors such as compromised retrograde axonal transport along 
the optic nerve, neurotrophin deprivation, increased oxidative stress or excitotoxic stress 
caused by glutamate impaired response (Almasieh et al., 2012). As in neurodegenerative 
diseases, like Alzheimer’s, Parkinson’s and Huntington’s diseases, glaucoma is 
characterized by neural cell death and inflammatory response. (Almasieh et al., 2012). The 
onset of the inflammatory response in glaucomatous disease is hypothesized to be mainly 
triggered by an altered crosstalk between RGCs and microglial cells, which in response to 
cell lesion highly express pro-inflammatory mediators, namely TNF, IL-1β, ROS and NO, 
perpetuating the neuroinflammatory milieu (Chua et al., 2012; Lee, 2013). Furthermore, in 
a genetic mouse model of glaucoma, DBA/2J, microglia activation was found to be an early 
event, even before ocular hypertension and RCG death (Bosco et al., 2011). Whether 
microglia activation is a cause or a consequence of glaucoma or whether it participates in 
the progression of the disease is yet to be clarified. Nevertheless, approaches that 
prevent microglia activation have been reported to be protective against RGC death 
(Almasieh et al., 2012; Langmann, 2007).  
 
1.5. Adenosine 
Adenosine is a ubiquitously expressed purine nucleoside that functions as a general 
modulator of biological functions, such as energy metabolism in the various systems 
throughout the body. Further research revealed other important functions of adenosine 
signaling in the immune system and in the CNS, being involved in cell growth, 
proliferation and apoptosis (Schulte and Fredholm, 2003).  
Adenosine is formed intracellularly, as well as extracellularly (Fig. 5). Intracellular 
formation of adenosine occurs either by the breakdown of adenosine 5’-phosphate (AMP, 
ADP, ATP) by an intracellular 5’-nucleotidase or through the hydrolysis of S-adenosyl- 
homocysteine (SAH). The levels of extracellular adenosine are modulated by two 
different mechanisms: through nucleoside transporters or fast nucleotide hydrolysis. 
There are two types of nucleoside transporters, the bi-dimensional equilibrative 
nucleoside transporters (ENTs) that through facilitated diffusion equilibrate 
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theintracellular and extracellular levels of adenosine, and the concentrative nucleoside 
transporters (CNTs) that are capable of maintaining high concentrations of adenosine 
against the gradient. Adenosine can also be produced by extracellular fast nucleotide 
hydrolysis catalyzed by a cascade of ectoenzymes (ecto-ATPase, ecto-ATP-
diphosphohydrolase and ecto-5’ nucleotidase) that convert adenine nucleotides into 
adenosine. Furthermore, adenosine is metabolized by phosphorylation to AMP or 
degraded to inosine, which is then catalyzed by adenosine kinase (AK) and adenosine 
deaminase (ADA), respectively (Fig. 5) (Fredholm et al., 2001). Adenosine is widely 
distributed within the retina being found in the GCL, IPL and INL, and to a lesser extent 
in the photoreceptors (Blazynski et al., 1989; Braas et al., 1987). 
 
 
1.5.1. Adenosine receptors 
Adenosine exerts its effects through the activation of four types of metabotropic 
membrane receptors, A1, A2A, A2b and A3. These receptors are coupled to intracellular 
GTP-binding proteins (G proteins) being composed of seven transmembranar domains 
Figure 5 - Adenosine signaling pathway and metabolism. In response to cellular stress or damage, ATP is 
released into the extracellular space being rapidly dephosphorylated by extracellular nucleotidases to form 
extracellular adenosine. Ecto-5’nucleotidase (ecto-5’NT). Extracellular adenosine can interact with the four types of 
adenosine receptors, that regulate secondary pathways and influence cell function. Extracellular adenosine can also 
be deaminated to inosine by adenosine deaminase (ADA) that can exist intracellularly, or extracellular. 
Furthermore, adenosine can be transported into cells via facilitated nucleoside transporters. Intracellular adenosine 
production is generated from the dephosphorylation of AMP by a cytosolic form of nucleotidase (cyto-5’NT), or 
the hydrolysis of S-adenosylhomocysteine (AdoHcy). Intracellular adenosine can be secreted or phosphorylated 
back to ATP. The first step in this process is catalyzed by adenosine kinase (AK). Alternatively, intracellular 
adenosine can be deaminated to inosine by ADA. Hcy: homocysteine. Adapted from (Blackburn, 2003). 
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with the N-terminus at the extracellular and the C-terminus at the intracellular face of 
the membrane. All adenosine receptors (AR) are pleiotropic receptors, being able to 
connect to different G proteins and to different transducing systems according to their 
localization and degree of activation (Cunha, 2005). The AR have distinct pharmacological 
and functional properties. A2AR and A2BR are coupled to a stimulatory G proteins (Gs), 
whereas A1R and A3R are coupled to an inhibitory G proteins (Gi/o), stimulating or 
inhibiting adenylyl cyclase (AC) activity, respectively (Fredholm et al., 2001; Hasko et al., 
2008; Kettenmann et al., 2011). A2BR and A3R feature a parallel signaling pathway through 
interaction with Gq proteins, which stimulates the activity of downstream enzymes such 
as protein kinase C (PKC) (Fig. 6) (Hasko et al., 2008). 
 Adenosine receptors are expressed in microglia and are involved in the regulation 
their function (Cunha, 2005; Hasko et al., 2008; Kettenmann et al., 2011). Furthermore, 
all adenosine receptors can be found in the retina (Zhong et al., 2013) and retinal neural 
cell cultures where they play a key role in modulating cell response (Vindeirinho et al., 
2013).  
 
Figure 6- Schematic diagram depicting the downstream signaling pathways of adenosine receptors. 
Adapted from (Dias et al., 2013). 
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1.5.1.1. A1 receptors  
The A1Rs are the most abundant and widespread AR in the brain, and are mostly 
expressed in limbic and neocortical regions (Cunha, 2005; Trincavelli et al., 2010). A1 
adenosine receptors signal through Gi/o pathways inhibiting AC. In addition, A1R are also 
linked to various kinase pathways including PKC, phosphoinositide 3 (PI3) kinase and 
mitogen-activated protein (MAP) kinases. A1R activation has been related to the inhibition 
of Ca2+ channels and the activation of K+ channels (Fig. 6) (Hasko et al., 2008; Linden, 
2001). 
They are also present in the retina, in the NFL, GCL, IPL, the inner portion of the 
INL, and ONL (Zhong et al., 2013), being present in neurons synapses, in astrocytes and 
microglia cells (Cunha, 2005). 
The neuroprotective properties of adenosine in epilepsy and against trauma and 
ischemia associated with brain injury have been hypothesized to be mainly mediated by 
the activation of A1R (Abbracchio and Cattabeni, 1999). This function has been linked to 
its ability to functionally diminish the release of excitatory mediators like glutamate, 
acetylcholine and serotonin in presynaptic neurons and its capacity to inhibit the 
excitatory potential of postsynaptic neurons. Furthermore, these actions confer potent 
depressant, anticonvulsant and sedative properties to A1R agonists by decreasing the 
metabolism rate. (Abbracchio and Cattabeni, 1999; Cunha, 2005). In RGC cell cultures, 
A1R agonist increased cell survival by decreasing the excitability of post-synaptic 
transmission (Perigolo-Vicente et al., 2013). 
The systemically administration of A1R agonists has potentially dangerous collateral 
effects by inducing profound sedation, hypotension, hypothermia and cardiovascular 
effects. Moreover, repeatedly activation of A1R may lead to its desensitization and loss of 
protective function (Abbracchio and Cattabeni, 1999). 
New therapies improving the selectivity of A1Rs in the brain open novel prospects to 
the treatment of neurodegenerative diseases by reducing collateral effects and the extent 
of desensitization (Abbracchio and Cattabeni, 1999). 
 
1.5.1.2. A2A receptors  
A2AR are facilitatory receptors being coupled to Gs proteins and leading to an 
increase in cAMP levels due to AC activity. On the other hand, increased levels of cAMP 
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lead to activation of protein kinase A (PKA), which follows through the phosphorylation 
of the transcription factor of cAMP responsive element binding protein (CREB), resulting 
in its activation (Fig. 6). Moreover, activated CREB can mediate gene expression showing 
the potential of A2AR to control cellular function (Hasko et al., 2008).  
A2AR were initially identified in the striatum being localized at postsynaptic neurons 
and implicated in the regulation of motor functions (Cunha, 2005). Further studies show 
that A2AR is also expressed in the hippocampus and cortex being most abundant pre-
synaptically. Moreover, A2ARs are also located in astrocytes and microglia, as well as in 
blood vessels (Cunha, 2005). A2AR is present in the retina being expressed in the GCL, 
INL, ONL (Zhong et al., 2013), and in retinal microglia cells (Liou et al., 2008). 
Furthermore, A2AR has been described to be increased following exposure to noxious 
and upon microglia activation (Cunha, 2005; Vindeirinho et al., 2013; Wittendorp et al., 
2004). 
 
1.5.1.3. A2B receptors 
A2BR once activated acts by modulating AC activity through Gs protein signaling, 
which conduces to an increase in cAMP formation leading to the activation of PKA that 
ultimately triggers CREB phosphorylation and activation (Schulte and Fredholm, 2003). In 
addition, A2BR has also been described to activate PKC and PI3 kinase pathways through 
interaction with Gq protein (Fig. 6) (Hasko et al., 2008; Schulte and Fredholm, 2003). 
A2BRs are present in different cell types like astrocytes and neurons but were not yet 
identified in microglia cells (Cunha, 2005). Comparing with other ARs, A2BRs are less 
abundant and exhibiting low affinity to adenosine (Schulte and Fredholm, 2003), meaning 
that adenosine concentration needs to be increased to pathological levels to trigger A2BR 
activation (Hasko et al., 2008).  
 
1.5.1.4. A3 receptors 
A3R activation is associated with Gi/o mediated AC inhibition and Gq mediated 
activation of PKC. Additionally, A3R activation modulates cell function by activation of PI3 
kinase pathways (Fig. 6) (Hasko et al., 2008; Schulte and Fredholm, 2003).  
The distribution of A3Rs in the brain is very diffuse being detected in all brain areas 
(Abbracchio and Cattabeni, 1999). Moreover, A3R can be found in different cell types like 
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neurons, microglia and astrocytes where their function is more evident (Cunha, 2005).  
The A3R is also expressed in the retina being found in the RGCs and RPE (Zhong et al., 
2013). 
The A3Rs are activated under specific noxious conditions since its activity is mediated 
by local high adenosine concentrations due to the low affinity of this receptor to 
adenosine. Furthermore, the A3R is thought to easily desensitize upon stimulus (de 
Mendonca et al., 2000). 
 
1.6. Neuroprotection mediated by A2AR 
Some studies indicate a controversial role for A2AR in inflammation. It is well 
documented that its activation is beneficial in peripheral inflammation conducting to an off 
signal (Hasko et al., 2008; Sitkovsky and Ohta, 2005), whereas in studies in CNS suggest a 
beneficial effect in the blockade of the A2AR (Rebola et al., 2011). In fact, recent research 
revealed a protective effect of A2AR blockade in neurodegenerative disorders like 
Huntington’s disease, Alzheimer’s disease, epilepsy and others (Cunha, 2005). The A2AR, 
modulates the funtions of microglia, namely chemotaxis and the production and release of 
inflammatory mediators (Gomes et al., 2013). Under inflammatory conditions, the 
responses of microglia are initially protective (acute neuroinflammation) but due to a 
deregulated microglia response its effect become noxious (chronic neuroinflammation) 
and leads to neural cell death (Almasieh et al., 2012; Gomes et al., 2013; Streit, 2000). 
Several results show that the blockade of A2AR provides neuroprotection by controlling 
microglia reactivity (Cunha, 2005). Furthermore, unlike A1R, the A2AR do not desensitize 
with prolonged administration of antagonists and can afford neuroprotection with 
considerably lower doses, producing less peripheral effects (Abbracchio and Cattabeni, 
1999; Cunha, 2005). These pharmacokinetic properties make A2AR antagonists particular 
interesting targets to develop novel and effective neuroprotective drugs. 
 
1.7. Elevated hydrostatic pressure model 
Several models of RGC death and elevated pressure have been developed to try to 
unravel the pathophysiological mechanisms underlying glaucomatous disease. Indeed, 
animal models with trabecular meshwork or episcleral vein obstruction have been used to 
increase hydrostatic pressure in the anterior chamber (Zeiss, 2013). Furthermore, optic 
nerve crush and ischemia-reperfusion injury have also been used as models of RGCs 
Introduction 
 
19 
degeneration characteristic of glaucoma. Several in vitro models of elevated hydrostatic 
pressure (EHP) have been developed to assess the cells response to pressure using 
different time points and pressure levels, ranging from 15 mmHg to 100 mmHg above 
atmospheric pressure (Agar et al., 2006; Agar et al., 2000; Reigada et al., 2008; Sappington 
et al., 2006). Previous studies described that the exposure of eyecup’s preparationss to 
increased hydrostatic pressure lead to an impaired glutamate signaling leading to Müller 
cells and retinal axonal swelling (Ishikawa et al., 2010, 2011), increased ATP release and 
neuronal cell death (Reigada et al., 2008). Moreover, reports in differentiated RGC cells 
exposed to increased pressure described that sustained moderate pressure elevation 
damage cell integrity by injuring mitochondria (Ju et al., 2009), increases extracellular ATP 
(Resta et al., 2007),  and triggers oxidative stress, being an early event in hydrostatic 
pressure induced neuronal damage (Liu et al., 2007). Studies using co-cultures of RCG 
and glial cells exposed to increased hydrostatic pressure showed and increased release of 
TNF by glial cells and conduced to RGC death (Tezel and Wax, 2000). In our EHP model, 
an increase of 70 mmHg above atmospheric pressure was used, based on previous 
findings on microglial cell response and RGC death (Sappington et al., 2006; Sappington et 
al., 2009). 
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Aims 
Glaucoma is a neurodegenerative disease characterized by RGC death and optic 
nerve atrophy. Elevated IOP is the main risk factor for disease development and despite 
IOP control current treatments are unable to prevent disease progression. Microglia-
mediated neuroinflammation is an important component of glaucoma. Recent evidences 
suggest that the control of the inflammatory milieu has great potential to attenuate RGC 
loss in retinal diseases like glaucoma. The blockade of the A2AR has been demonstrated to 
afford robust neuroprotection against several brain noxious conditions by modulating 
microglia activation and the onset of the inflammatory response. Several approaches have 
been developed to unravel the pathophysiological mechanisms underlying RGC loss in 
glaucoma. 
The aim of this work was to assess the effects of A2AR blockade on pressure-induced 
microglia activation and retinal cell death, disclosing the potential neuroprotective effects 
arising from SCH 58261, a selective A2AR antagonist (Fredholm et al., 2001). 
To achieve our goals we used three experimental models: primary retinal neural cell 
cultures, a microglia cell line (BV-2) and retinal organotypic cultures. The cultures were 
submitted to 70 mmHg above atmospheric pressure to mimic the increase in IOP 
described in glaucoma. The expression and release of pro-inflammatory cytokines, the 
production of ROS, as well as cell death and microglia morphology were assessed. The 
role of A2AR blockade was evaluated pharmacologically by pre-treating the cultures with 
SCH 58261. Furthermore, organotypic retinal cell cultures were prepared from wild type 
and A2AR-KO mice, in order to investigate the role of A2AR in the changes of microglia 
morphology upon exposure to EHP. 
In summary (Fig. 7), we hypothesize that EHP elicits microglia activation increasing its 
proliferation, migration and the release of inflammatory mediators, like IL-1β, TNF, ROS 
and NO. Furthermore, we hypothesized that A2AR antagonist prevents EHP-induced 
microglia reactivity 
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Figure 7 - Mechanisms hypothesis of the effects operated by EHP and A2AR blockade. 
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“Microglia cell – Primary retinal neural cell culture” 
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2. Methods 
2.1. Animals 
All animals used in this study, wild type mice and A2AR-KO mice C57BL/6 and Wistar 
rats were housed under controlled environment (21.8±0.1°C of temperature and, 
67.6±1.6% of relative humidity, 12 h-light/dark cycle) with free access to food and water. 
The animals were treated in agreement with the Association for Research in Vision and 
Ophthalmology (ARVO) statement for the use of animals in vision and ophthalmic 
research. 
 
2.2. Mice genotyping  
 Tissue samples were obtained by tail biopsy in accordance with FELASA guidelines 
and DNA was isolated for further genotype assessment. Briefly, the tissue samples were 
digested using a lysis buffer solution (5 mM EDTA, 200 mM NaCl, 100 mM Tris, 0.3% 
sodium dodecyl sulfate (SDS), pH 8.0) and 20 mg/ml proteinase K for 4 h at 55°C. The 
solution was centrifuged at 13400 g for 15 min. The supernatant was collected and ice-
cold 100% ethanol was added. The samples were centrifuged at 1500 g for 15 min and the 
supernatant was discarded. The pellet was ressuspended in 75% ethanol and centrifuged 
at 1500 g for 15 min. The supernatant was discarded and the samples were left to dry 
overnight. The pellet was then dissolved in Tris-EDTA (TE) buffer (10 mM Tris-HCl, 1 
mM EDTA, pH 8.0) and heated at 70°C for 10 min. DNA concentration and purity were 
determined using NanoDrop ND-1000. Samples were then submitted to a standard end-
point PCR using a mix of DNA polymerase (Invitrogen), dNTP’s (Nzytech) and custom-
designed primers (Life Technologies) (see table 1).  
 
 
Tabela 1 - PCR primes sequence for genotyping 
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The PCR conditions were as follows: initial denaturation 4 min at 94°C, 30 seconds 
at 94°C, 30 seconds at a 55°C and 50 seconds at a 72°C for 35 cycles, and a final cycle of 
7 min at 72°C. Samples were then kept at 4°C. Resulting samples were then subjected to 
electrophoresis in a 1.5% agarose gel with 5% ethidium bromide, at 150 v for 35 min, 
being then observed in a transilluminator (Versadoc, Bio-Rad) and compared with a 
standard ladder (NZYDNA Ladder V, Nzytech) (Fig. 8). 
 
2.3. Primary retinal neural cell cultures  
Retinal neural cell cultures were prepared from 3-5 days old rats, as described in 
Santiago et al. (2006). Briefly, the animals were sacrificed by decapitation being the eyes 
collected and kept on ice in Hanks balanced salt solution (HBSS in mM: 137 NaCl, 5.4 
KCl, 0.45 KH2PO4, 0.34 NaHPO , 4 NaHCO3 , 5 glucose; pH 7.4). The retinas were 
dissected and the tissue was then digested with trypsin (0.1% (w/v)) for 12 min at 37°C. 
The cell suspension was centrifuged at 1280 g for 1 min. Supernatant was carefully 
discarded and the pellet was resuspended in Eagle’s minimum essential medium (MEM) 
supplemented with 26 mM NaHCO3, 25 mM HEPES, 10% heat-inactivated fetal bovine 
serum (FBS), penicillin (100 U/ml) and streptomycin (100 µg/ml). Cells were then plated 
at a density of 2x106 cells/cm2, in 12 well-plates with glass coverslips, or 6 well-plates, all 
pre-coated with poly-D-lysine (0.1 mg/ml). Cells were cultured at 37°C in a humidified 
atmosphere of 5% CO2 for seven days. The mixed culture is composed of retinal neurons, 
Müller cells and microglia.  
 
2.4. BV-2 cell line  
BV-2 cells (murine microglia) were cultured in 25 cm2 flasks in Roswell Park 
Memorial Institute medium (RPMI) supplemented with 10% FBS and antibiotics (penicillin 
100 U/ml, streptomycin100 µg/ml). Medium was changed every 3 days. 
180 bp 
320 bp 
(+/-) (-/-) (+/+
Figure 8 - Representative PCR analysis of DNA from mouse tail tissue. The specific set of primers 
designed for A2AR gene and for internal Neo cassette generated a 180 or 320bp, respectively. 
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For experiments, BV-2 cells were cultured in RPMI supplemented with 2% FBS and 
antibiotics  (penicillin 100 U/ml, streptomycin 100 µg/ml) at a density of 6x104 cells/cm2  in 
6 well plates or at a density of 4x105 cells/cm2  at 12 well plates, and cultured at 37°C in a 
humidified atmosphere of 5% CO2. 
 
2.5. Retinal explants  
 Retinal explants were obtained from wild type mice and A2AR-KO mice C57BL/6 by 
enucleating the eyes and fully dissect the retina. Retinas were cultured for 4 days in 
culture inserts (12 mm, hydrophilic PTFE, 0.4 µm pore diameter, Millipore) in a cell 
incubator at 37°C in a humidified atmosphere of 5% CO2. Retinal explants were subjected 
to EHP for 4 or 24 h or kept at a standard incubator (Fig. 9).  
 
 
 
2.6. Cell treatment 
Cell cultures were pre-treated with A2AR selective antagonist (50 nM, SCH 58261) 45 
min before the insult. The cells were challenged with EHP (70 mmHg above atmospheric 
pressure) for 4 or 24 h (Fig. 10).  
 
 
EHP conditions were maintained as described previously (Sappington et al., 2006). 
Briefly, the pressure chamber consists of a custom-made humidified pressure chamber 
that is equipped with a regulator and a gauge and placed in a 37°C incubator. Elevated 
pressure is obtained by injecting a mixture of 95% air 5% CO2 into the chamber until +70 
Figure 10– Schematic representation of primary mixed retinal cell cultures experimental procedure. 
A B 
Figure 9 - (A) Image depicting organotypic retinal cell culture. (B) Schematic representation of 
organotypic retinal cell cultures experimental procedure. 
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mmHg hydrostatic pressure is achieved (9% increase above atmospheric pressure). The 
EHP was continuously maintained inside the chamber (Fig. 11).  
Control cultures cells were kept at atmospheric pressure in a standard incubator. In 
some experiments, retinal neural cell cultures and BV-2 cell cultures were treated with 
1µg/ml or 100 ng/mL of lipopolysaccharide (LPS), respectively, for 24h. LPS is a 
component of the Gram-negative bacteria cell membrane, which is a well-characterized 
inflammatory stimulus able to induce microglial activation, used in this study as a positive 
control (Rebola et al., 2011). 
Retinal neural cell cultures were incubated with 100 µM kainate (KA) and 30 µM 
ciclotiazide (CTZ) for 24 h as a cell death positive control.  
 
2.7. Immunocytochemistry 
2.7.1. Cell cultures 
The cells was washed with warm phosphate-buffered saline (PBS; in mM: 137 NaCl, 
2.7 KCl, 10 Na2HPO4, and 1.8 KH2PO4; pH 7.4) and then fixed using 4% 
paraformaldehyde (PFA) with 4% sucrose for 10 min. After fixation, the cells were 
washed with PBS and permeabilized in 1% Triton X-100 in PBS for 5 min. Next the 
cultures were blocked with 3% Bovine Serum Albumin (BSA) and 0.2% Tween, in PBS, for 
60 min. Coverslips were then incubated with the primary antibodies (see table 2) for 90 
min. Subsequently cells were rinsed with blocking solution and incubated with the 
secondary antibodies, (see table) for 60 min. After cells were washed with PBS and 
incubated with 4',6-diamidino-2-phenylindole (DAPI) (1:2000) for 10 min. The coverslips 
were them again washed with PBS and mounted with Glycergel mounting medium.  
 
Figure 11– Image depicting the pressure chamber. Humidified pressure chamber equipped with a regulator 
to ensure + 70 mmHg, and placed at 37°C. 
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2.7.2. Organotypic retinal cell cultures 
Organotypic cultures were washed with PBS and fixed for 10 min with ice-cold 
ethanol at 4ºC. Following wash in PBS, cultures were blocked with 10% goat serum, 3% 
BSA and 0.1% Triton X-100 in PBS, for 1 hour, and then incubated with the primary 
antibody against Iba-1 (Table 2) for 48 h at 4ºC. After washing, cultures were incubated 
overnight with the secondary antibody anti-rabbit alexa fluor 568, at 4ºC. Subsequently, 
retinas were washed and incubated with DAPI (1:1000) for 20 min. Next, retinas were 
washed and flat-mounted on slides and coverslipped using Glycergel mounting medium. 
The preparations were observed with a confocal microscope (LSM 710, Zeiss), and 8 
random fields covering the four quadrants were acquired from each condition.  
 
2.8. Densitometric analysis of iNOS immunoreactivity 
Quantitative analysis of total fluorescence in a cell was performed from images of 
primary retinal cell cultures immunostained for inducible nitric oxide synthase (iNOS) and 
CD11b. iNOS immunoreactivity was quantified using the public domain ImageJ program 
(http://rsb.info.nih.gov/ij/). Cell immunoreactivity was calculated using the corrected total 
cell fluorescence (CTCF), following the formula, as previously described in (Gavet and 
Pines, 2010):  
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Tabela 2 - List of primary and secondary antibodies used in immunofluorescence labeling. 
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2.9. Reactive oxygen species quantification by dihydroethidium 
staining 
The production of ROS was assessed by dihydroethidium (DHE) staining. DHE is a 
probe that is oxidized to ethidium in the presence of the superoxide anion (O2-) and 
intercalates with DNA emitting red fluorescence that can be observed by microscopic 
analysis. Briefly, cell medium was collected and the cells were incubated with 5 µM DHE 
in fresh culture medium for 1h in the cell incubator. Then, the medium was replaced by 
the previous collected medium and the cells were cultured for 4h. The cell cultures were 
rinsed with warm PBS, fixed, and immunostained for CD11b, as previously described. 
Cells were observed with a confocal microscope (LSM 710, Zeiss), and from each 
condition 5 random fields were acquired. The number of CD11b-immunoreactive cells 
stained with DHE per field was counted.   
 
2.10. Nitrite quantification assay 
The production of NO in primary retinal cell cultures was assessed by the Griess 
reaction method. The culture medium was collected and centrifuged to remove cell 
debris and then incubated (1:1) with Griess reagent mix (1% sulfanilamide, in 5% 
phosphoric acid with 0.1% N-1-naphtylenediamine) for 30 min, protected from light. The 
optical density was measured at 550 nm using a microplate reader (Synergy HT; Biotek, 
Winooski, USA). The nitrite concentration was determined by comparison to a sodium 
nitrite standard curve. 
 
2.11. Assessment of cell morphology  
Morphological alterations were assessed using an automated feature of ImageJ as 
previously described (Kurpius et al., 2006). First, threshold was arbitrarily but uniformly 
applied to confocal images labeled with CD11b. Next, the particle measurement feature 
of ImageJ (http://rsb.info.nih.gov/ij/) was used to automatically measure the 2D area, 
perimeter, Feret’s diameter and circularity index. A circularity value of 1.0 indicates 
perfect circular cell and values near to zero indicate elongated cells. Feret’s diameter is 
the greatest distance between two points along the perimeter. 
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2.12. Cell proliferation assay 
Cell proliferation was assessed using the Click-iT® EdU cell proliferation assay 
according to the instructions provided by the manufacturer (Life Technologies). The 
principle of the kit is the incorporation of a nucleoside analog of thymidine, EdU (5-
ethynyl-2´-deoxyuridine), into DNA in the S phase of the cell cycle. EdU is coupled to a 
fluorophore (Alexa Fluor 488) for microscope vizualization. Briefly, half of the culture 
medium was replaced by fresh medium containing the EdU solution (final concentration of 
10 µM) and incubated for 24h until the end of the experiment. Cells were rinsed, fixed, 
permeabilized and blocked as previously described. Next, cells were incubated for 30 min 
with the Click-iT® reaction cocktail, followed by immunostaining for CD11b as previously 
described. Nuclei were stained with Hoechst 33342 (1:2000). Cells were observed with a 
confocal microscope (LSM 710, Zeiss), and from each condition, 5 random fields were 
acquired. The number of EdU-positive cells was counted. Results represent the average of 
EdU-positive cells per field and the percentage of CD11b-positive cells stained with EdU. 
 
2.13. Terminal deoxynucleotidyl transferase (TdT)-mediated dUTP 
nick end labeling (TUNEL) assay 
To detect apoptotic cells DeadEnd™ Fluorometric TUNEL System was used 
following manufacturer’s instructions (Promega). TUNEL assay assesses cell apoptosis by 
labeling DNA fragments by catalytically incorporating fluorescein-12-dUTP at 3´-OH 
DNA ends using the recombinant Terminal Deoxynucleotidyl Transferase (rTdT). 
Cultures were immunostained for CD11b and then incubated with TUNEL reaction 
cocktail for 60 min at 37°C. The nuclei were then stained using DAPI (1:2000). Cells were 
observed with a confocal microscope (LSM 710, Zeiss), and from each condition, 5 
random fields were acquired. The total number of TUNEL-positive cells and the number 
of CD11b-immunireactive cells stained with TUNEL were counted. Results represent the 
average of TUNEL-positive cells per field and the percentage of CD11b-positive cells 
marked with TUNEL in the cytoplasm. 
 
2.14. Phagocytosis assay 
Phagocytosis was assayed with fluorescent latex beads (1 µm diameter), as previously 
described (Pan et al., 2011) with minor modifications as follows, BV-2 cells were 
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incubated with 0.025% beads for 60 min at 37°C. Then, the cells were fixed, 
permeabilized and blocked. Primary cultures were processed for immunostaining anti-
CD11b as described previously, and BV-2 cells were stained with Phalloidin conjugated to 
Tetramethylrhodamine B isothiocyanate (TRITC) (1:500; Sigma-Aldrich). Phalloidin 
selectively binds to F-actin, allowing visualization of BV-2 cells. Nuclei were stained with 
DAPI (1:2000). Cells were observed with a confocal microscope (LSM 710, Zeiss), and 
from each condition, 5 random fields were acquired. The number of beads phagocytized 
by each cell was counted as well as the number of cells with incorporated beads. 
Phagocytic efficiency (%) was then calculated as described in (Pan et al., 2011): 
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! represents the number of cells containing  microspheres ( = 1,2,3, ... up to a 
maximum of 6 points for more than 5 microspheres ingested per cell).  
 
2.15. Scratch wound assay 
Confluent BV-2 cells, plated in 6-well plates, were wounded with a sterile p200 pipet 
tip and after washing to remove non-adherent cells, then were cultured for 4h. As 
previously described in (Yuskaitis and Jope, 2009) with minor modifications. Images were 
acquired before, immediately and 4h after the wound (Fig. 12) with an inverted 
fluorescence microscope (LEICA DMIRE2). The number of cells in the wound was 
counted.  
 
2.16. Boyden chamber migration assay 
BV-2 cells were kept in serum free medium 24h before the beginning of the 
experiment and plated with 2% FBS serum in transwell cell culture inserts (8.0 µm pore 
Figure 12 – Schematic representation of Scratch wound assay experimental procedure. Images were 
acquired in tree points as depicted. Cells were plated, wounded with a sterile p200 pipet tip and cultured for 4h 
under EHP. 
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diameter, Merck Millipore) at a density of 3x104 cells/cm2 and were cultured for 4 h, as 
described in (Yuskaitis and Jope, 2009) with some modifications (Fig. 13). 
Culture inserts were then washed with warm PBS and the cells in upper side were 
removed with a cotton swab, following fixation in 4% PFA with 4% sucrose for 10 min. 
Nuclei were stained with DAPI (1:2000) to allow cell counting, as described (Siddiqui et 
al., 2012). The membrane was removed and mounted with Glycergel in glass slides. The 
preparations were observed in an inverted fluorescence microscope (LEICA DMIRE2) 
and 5 random images per insert were acquired. The number of cells in the bottom side of 
the insert (the cells that migrated) was counted. 
 
2.17. Determination of adenosine concentration by high 
performance liquid chromatography  
Extracellular adenosine was quantified using high performance liquid chromatography 
(HPLC), with detection at 254 nm, as previously described in (Vindeirinho et al., 2013). 
Briefly, cell culture medium was collected and immediately stored at -80°C until further 
processing. The samples were then analyzed in Beckman-System Gold, HPLC apparatus, 
with a computer controlled 126 Binary Pump Model using a 166 Variable UV detector 
and a Lichrospher 100 RP-18 (5 mm) from Merck column. An isocratic elution with 10 
mM phosphate buffer (NaH2PO4; pH 6.0) and 14% methanol was performed with a flow 
rate of 1.5 ml/min. Adenosine was quantified by retention time, absorption spectra and 
comparison with the standard curve. Results were presented in pmol/µg of protein which 
was quantified by bicinchoninic acid (BCA) protein assay (Pierce Biotechnology).  
 
Figure 13 - Schematic representation of Boyden chamber migration assay experimental procedure. 
Cells were plated in the upper side of the transwell cell culture inserts and submitted to EHP for 4h. 
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2.18. Determination of ATP concentration by luciferin-luciferase 
bioluminescence assay 
The extracellular levels of ATP were quantified using the luciferin-luciferase 
bioluminescence assay. This method is based on the enzymatic reaction which converts 
luciferin to its oxidated form luciferase in the presence of ATP, being this response 
dependent to the ATP availability and allowing the assessment of ATP concentrations 
ranging between 2x10-12 M and 8x10-5 M. This reaction leads to light emission at 565 nm 
proportional to ATP levels, which were measured using a VICTOR multilabel plate reader 
(Perkin Elmer). Briefly, cell medium was collected and immediately stored at -80°C, until 
used. Samples were quickly defrosted and incubated with ATP assay mix (Sigma-Aldrich), 
designed for bioluminescence, in an opaque white 96-well plate. The plate was then read 
at luminometer for 5 seconds. ATP concentrations were determined by comparison with 
a standard curve obtained from an ATP sock provided. Results are presented pmol/µg of 
protein which was quantified by BCA protein assay (Pierce Biotechnology). 
 
2.19. RNA extraction  
The cells were washed with ice-cold autoclaved PBS and then lysed with TRIZOL 
reagent (Life Technologies). Cell monolayer was then disrupted using a p1000 pipet tip, 
collected and kept overnight at -80°C. Samples were then defrosted and chloroform was 
added being the tubes vigorously shaken to promote homogenization of the mixture and 
incubated for 5 min on ice. Then samples were centrifuged at 12000 g for 15 min at 4°C 
to assure phase distribution. Upper aqueous phase was collected to a new tube and RNA 
was precipitated with isopropanol. Glycogen (20 µg) (Invitrogen, Life Technologies) was 
added as a carrier to facilitate precipitation. Samples were kept at -20°C overnight, and 
then centrifuged at 12000 g for 30 min at 4°C. The pellets were washed twice with 
ethanol, and RNA was resuspended in RNase-free water.  RNA concentration and purity 
were determined using NanoDrop®. Resulting RNA samples were treated with 
Deoxyribonuclease I (DNase I) (amplification grade, Invitrogen, Life Technologies) to 
eliminate possible contamination with genomic DNA. 
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2.20. Reverse transcription 
RNA samples were reversed transcribed to cDNA using NZY M-MuLV First-Strand 
cDNA Synthesis Kit, according to supplier’s instructions (NZYTech). Briefly, RNA was 
incubated for 10 min at 25°C with NZYRT 2x Master mix and NZYRT Enzyme Mix, 
followed by a 30 min step at 50°C and a final step at 85°C to stop the reaction. The 
cDNA obtained was then treated with RNAse H for 20 min at 37°C to eliminate the 
remaining RNA-DNA hybrids. To confirm cDNA synthesis and purity a standard end-
point PCR for β-actin, using intron-spanning primers (table 3), using 2x MyTaq Red Mix 
(Bioline), was performed. Briefly, 1 µl of cDNA was incubated with 2x MyTaq Red Mix 
under the following conditions: 1 min initial denaturation at 95°C, followed by 35 cycles 
of denaturation at 95°C for 15 seconds, annealing at 55°C for 15 seconds, elongation at 
72°C for 10 seconds. Resulting samples were then subjected to electrophoresis in a 1.5% 
agarose gel with 5% ethidium bromide, at 150v for 35 min, being then observed in a 
transilluminator (Versadoc, Bio-Rad). The cDNA samples were diluted 1:2 and kept at -
20°C until further qPCR analysis. 
 
 
 
 
 
Tabela 3 - Primers used for qPCR. 
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2.21. Real-time quantitative PCR 
 Cell cultures mRNA expression was quantified by qPCR in a 7500 Real-Time PCR 
System (Applied Biosystems) using SYBR Green to detect the amplification products. 
Samples were plated with SYBR Green (BioRad) and pre-optimized, custom-designed 
primers (Sigma-Aldrich), see table 3.  
The plate was then submitted to the following protocol (Fig. 14):  
 
Three housekeeping candidate genes were tested, namely YWHAZ, HPRT and TBP. 
All samples were analyzed using NormFinder (Andersen et al., 2004), and the most stable 
gene among all samples and conditions was used as housekeeping gene. In our conditions, 
YWHAZ was the most stable gene. Relative quantification of mRNA expression was 
calculated by the comparative cycle threshold (Ct) method after the target genes levels 
were normalized to the expression of YWHAZ for each sample. The fold difference in 
gene expression between treated groups was calculated as follows: 
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2.22. Quantification of pro-inflammatory cytokines 
T The quantification of IL-1β and TNF was performed using enzyme-linked 
immunosorbent assay (ELISA), in accordance with the manufacturer’s instructions. Briefly, 
culture medium was collected and kept at -80°C until further analysis. To perform the 
Figure 14 – Schematic representation of the qPCR cycles temperature profile. 
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quantification the samples were defrosted and kept on ice, all the reagents needed for this 
assay were kept at room temperature.  
IL-1β levels were quantified in retinal neural cell cultures growth medium after 
exposure to 4 and 24 h EHP, using Peprotech ELISA kit. Briefly, a 96-well plate was 
coated with the capture antibody overnight, next the plate was washed 4 times and a 
standard curve was prepared and loaded into the plate as well as the samples. The plate 
was left overnight at 4°C. The samples were removed and the plate was washed 4 times 
following incubation with the detection antibody for 2h at room temperature. The plate 
was again washed and incubated with avidin peroxidase for 30 min. After a final wash, the 
reaction subtract was added to each well. Readings of the OD were collected for 2h in 5 
min intervals at 405 nm with wavelength correction set at 650 nm, using a microplate 
reader (Synergy HT; Biotek, Winooski, USA). 
TNF and IL-1β level´s in BV-2 cell culture medium exposed to 24h LPS, 4h and 24h 
EHP, using R&D Systems ELISA kit. The procedure was the following: a standard curve 
was prepared to allow quantification of the samples by comparison, samples and 
standards were then placed in a 96-well plate, pre coated provided with the kit, and 
incubated for 2 h at room temperature. The plate was washed 5 times and incubated with 
the conjugate, provided with the kit. After 2h the plate was washed and the substrate 
solution was added to each well and incubated for 30 min, protected from light. Following 
this, stop solution was added and the optical density was measured at 540 nm or 570 nm, 
to corrected readings, using a microplate reader (Synergy HT; Biotek, Winooski, USA). 
Results are expressed as percentage of control or in pictograms per milliliter (pg/ml). 
 
2.23. Preparation of frozen retinal sections 
Animals were deeply anesthetized with an intraperitoneal injection of a solution of 
ketamine (90 mg/kg; Imalgene 1000) and xylazine (10 mg/kg; Ronpum 2%) and then 
transcardially perfused with phosphate-buffered saline (PBS, in mM: 137 NaCl, 2.7 KCl, 10 
Na2HPO4, 1.8 KH2PO4; pH 7.4) followed by 4% PFA. The eyes were enucleated and post-
fixed in 4% PFA for 1h. Then, the cornea and the lens were carefully dissected out and 
the eyecup was fixed for an additional 1 hour in 4% PFA. After washing in PBS, the tissue 
was cryopreserved in 15% sucrose in PBS for 1h followed by 30% sucrose in PBS for 1h. 
The eyecups were embedded in tissue-freezing medium (Optimal Cutting Temperature, 
OCT; Shandon Cryomatrix, Thermo Scientific) with 30% of sucrose in PBS (1:1), and 
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stored at -80°C. The tissue was sectioned on a cryostat (Leica CM3050 S) into 16 µm 
thickness sections and mounted on Superfrost Plus glass slides (Menzel-Glaser, Thermo 
Scientific). Glass slides were dried overnight and then stored at -20°C. 
 
2.24. Assessment of retinal structure 
After defrosting the slides at room temperature overnight, the sections were 
rehydrated in PBS twice (5 min). Then the sections were incubated with hematoxylin 
solution for 3 min, followed by a superficial wash (3 seconds) with HCl 0.1% solution. The 
sections were washed in running tap water for 5 min, and then incubated with 0.5% eosin 
in 100% ethanol for 3 min. The sections were then washed in running tap water for 30 
seconds and then dehydrated in ascending alcohol solutions (95% and 100%, 1 min each). 
Then, sections were cleared through 2 changes of xylene (5 min). Finally, tissue sections 
were mounted with DPX mounting medium (FLUKA). 
 
2.25. Statistical analysis 
Results are presented as mean ± SEM. Statistical significance was determined using a 
non-parametric Kruskall-Wallis test, followed by Dunn’s multiple comparison test or a 
non-parametric Mann-Whitney test. Groups were considered significantly different for 
p<0.05. 
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3. Results  
 
Elevated IOP is the main risk factor for glaucoma. We aimed to investigate, using an 
in vitro system, the alterations induced by EHP in microglia. Therefore, elevated IOP was 
mimicked in vitro by exposing the cells to EHP (70 mmHg above atmospheric pressure) 
for 4 hours and 24 hours. In addition, in several experiments, we also investigated the 
role of A2AR blockade in the control of microglia responses. 
Cells were also incubated with LPS, a component of Gram-negative bacteria wall, that 
acts through toll-like receptor 4 (TLR4) in immune cells. Accordingly, the LPS condition 
was mostly used as a “control” of the inflammatory cells response, because it is widely 
known that microglia become reactive upon TLR4 activation (Hines et al., 2013). 
Therefore the results obtained in this condition were not considered for statistical 
purposes. 
 
3.1. Effect of elevated hydrostatic pressure in the expression of 
A2AR in primary retinal neural cell cultures  
Primary retinal neural cell cultures were challenged with LPS (1 µg/ml) or EHP for 4 
hours or 24 hours and A2AR mRNA expression was assessed by qPCR (Fig. 15). LPS 
increased the transcript levels of A2AR by 9.1±5.1 fold. Exposure to EHP for 4h and 24h 
changed the transcript levels of A2AR to 1.6 ± 0.8 and 3.2 ± 2.1 fold, respectively. 
 
Figure 15 - Effect of elevated hydrostatic pressure in the expression of A2AR in primary retinal 
neural cell cultures. Primary mixed retinal cultures where challenged with 1 µg/ml LPS or EHP for 4 or 24 hours 
and A2AR mRNA expression was assessed by qPCR. Results are expressed in fold change of control, from 3 to 4 
independent experiments, performed in duplicate. 
0
2
4
68
10
12
14
16
Control 24h EHP4h EHPLPS
A
2
A
R
 m
R
N
A
 e
x
p
re
ss
io
n
(n
o
rm
a
li
z
e
d
 t
o
 c
o
n
tr
o
l)
Results 
 
42 
3.2. Elevated hydrostatic pressure increases oxidative/nitrosative 
stress in primary retinal cultures 
Oxidative stress caused by increased production of ROS and NO has been described 
as a major hallmark in glaucomatous neurodegeneration (Tezel et al., 2007). The effect of 
EHP on the expression of iNOS and NO production was evaluated in primary retinal 
neural cell cultures. In addition, the effect of A2AR blockade was also investigated by 
incubating the cells with 50 nM SCH 58261, a selective A2AR antagonist, prior the 
exposure to EHP. In control conditions, iNOS immunoreactivity was barely detected but 
when the cells were incubated with LPS the immunoreactitivy of iNOS, as expected, was 
increased, mainly in CD11b-immunorreactive cells, a marker of microglia (Fig. 16A). In 
order to compare the magnitude of the cells’ response between LPS and EHP, the 
microscope settings were kept identical. When the cells were exposed to EHP for 24h 
the immunoreactivity of iNOS in microglia significantly increased by 192.8±28.3% of the 
control (p<0.05), as compared with the control (Fig. 16A and B). When the cells were 
treated with A2AR antagonist, the immunoreactivity of iNOS was similar to the control. 
We also evaluated the expression of iNOS by qPCR (Fig. 16C). Preliminary results show 
that the transcript levels of iNOS increased after 24 hours of EHP (2.3±1.1) and the 
blockade of A2AR may inhibit this alteration (0.4±0.2). The production of NO was 
assessed by quantifying nitrites in cell culture medium by the Griess reaction method. In 
control conditions, nitrite concentration was 4.1±0.2 µM (Fig. 16D) and incubation with 
LPS increased nitrite concentration to 320.2±23.2% of the control. Exposure of the cells 
to EHP for 24 hours significantly increased nitrite concentration to 129.5±13.7% of 
control (p<0.01). The blockade of A2AR significantly prevented the effect of EHP on nitrite 
concentration (p<0.05). 
To investigate whether EHP changes oxidative stress, primary retinal neural cell 
cultures were exposed for 4h to EHP and the production of ROS production was 
evaluated with DHE. Incubation with LPS for 4h increased the number of cells stained 
with DHE (Fig. 17A). When the cells were exposed to EHP for 4h, the number of cells 
stained with DHE significantly increased (p<0.01) to 29.5±7.9 cells per field (Fig. 17B), 
which corresponds to a 2.5-fold increase, compared with the control.  
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Figure 16 - Elevated hydrostatic pressure increases oxidative stress in primary retinal cultures.
Primary mixed retinal cultures were pre-treated with 50 nM SCH 58261, followed by 1 µg/ml LPS or EHP for 24 
hours. (A) Representative images of microglia stained with CD11b (red) and iNOS (green). Nuclei were stained 
with DAPI (blue). (B) Densitometric analysis for iNOS immunoreactivity was determined using ImageJ, and results 
are expressed in percentage of control, from 4 to 5 independent experiments, performed in duplicate. (C) iNOS 
mRNA expression was assessed by qPCR. Results are expressed in fold change of control from 3 to 4 independent 
experiments, performed in duplicate. (D) Nitrite concentration was determined in culture medium supernatants, 
and was expressed in percentage of control, from 5 to 6 independent experiments, performed in duplicate. *p<0.05, 
**p<0.01, ***p<0.001, Kruskall-Wallis test, followed by Dunn’s multiple comparison test. Bar: 100 µm. 
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3.3. Effect of elevated hydrostatic pressure in the expression and 
release of TNF and IL-1β in primary mixed retinal neural cell 
cultures 
We evaluated whether the exposure of primary retinal neural cell cultures to EHP 
changed the expression and release of pro-inflammatory cytokines TNF and IL-1β, by 
qPCR and ELISA, respectively. In cultures exposed to EHP for 4h, the expression of IL-1β 
transcript levels by qPCR was not different from the control due to the variability of the 
results and inferences can not be made. These effects were not noticeable in cultures 
exposed to EHP for 24h where the transcript levels of IL-1β were kept similar to control 
(0.9 ± 0.8) fold (Fig. 18A). Nevertheless, the levels of extracellular IL-1β assessed by 
ELISA were altered by the exposure to EHP for 4h being significantly increased to 
233.0±70.9% of control (p<0.05). Furthermore when the cells were exposed for 24h to 
EHP, IL-1β levels increased to 167.9±45.6% of control. In control conditions the levels of 
IL-1β were 275.2±58.6 pg/ml (Fig. 18B). The effect of LPS for 24h was similar to 4h EHP 
(228.0±55.3% of the control).  
Figure 17 - Elevated hydrostatic pressure increases ROS production in primary mixed retinal 
cultures. The production of ROS in retinal primary mixed cultures was assessed with DHE probe after 4 hours 
with 1 µg/ml LPS or EHP. (A) Representative images of DHE staining (red). Nuclei were stained with DAPI (blue). 
(B) The number of DHE-labeled cells was counted, and the results are expressed as percentage of control, from 3 
to 5 independent experiments. *p<0.05, Kruskall-Wallis test, followed by Dunn’s multiple comparison test. Bar: 20 
µm. 
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TNF mRNA expression levels were also quantified using qPCR (Fig. 18C). LPS 
increased TNF mRNA expression by 10.9± 6.1 fold. Preliminary results suggest that EHP 
may change the expression of TNF after 4h or 24h exposure to EHP.  
 
3.4. Effect of A2AR blockade cell death induced by elevated 
hydrostatic pressure in retinal neural cell cultures  
Primary retinal neural cell cultures were exposed to EHP for 4h and 24h and cell 
death was evaluated by TUNEL assay. Cells were pre-treated with A2AR antagonist (50 
nM SCH 58261). Glutamatergic excitotoxicity is known to induce cell death to retinal 
neurons (Ishikawa, 2013). Therefore, cells were incubated with 100 µM kainate (KA) and 
30 µM cyclothiazide (CTZ) for 24h to induce an excitotoxic insult (positive control of cell 
death).  
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Figure 18 - Effect of elevated hydrostatic pressure in the expression and release of TNF and IL-1β in 
primary mixed retinal neural cell cultures. Primary mixed retinal cultures were challenged with EHP for 4 
hours or 24 hours or 1 µg/ml LPS for 24 hours. IL-1β (A) and TNF (B) mRNA expression was assessed by qPCR 
and results are expressed as fold change of control, from 3 to 4 independent experiments, performed in duplicate.  
(C) Extracellular levels of IL-1β were quantified by ELISA in cell culture medium supernatants, and the results are 
expressed as percentage of control, from 3 to 4 independent experiments. *p<0.05, Kruskall-Wallis test, followed 
by Dunn’s multiple comparison test. 
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Figure 19- The effect of A2AR blockade in elevated hydrostatic pressure induced cell death and dead 
cells engulfment by microglia in primary mixed retinal neural cell cultures. Primary mixed retinal 
cultures were pre-treated with 50 nM SCH 58261 and challenged with EHP for 4 or 24 hours.  As a positive control 
cell cultures were incubated with 100µM kainate (KA) and 30µM cyclotiazide (CTZ) for 24 hours. Cell death was 
assessed with TUNEL (green) assay. Microglial cells were identified by immunocytochemistry with anti-CD11b 
(red). Nuclei were counterstained with DAPI (blue). Representative images are depicted in A. (B) The number of 
TUNEL+ was counted and results are expressed as percentage of control, from 6 to 9 independent experiments, 
performed in duplicate. (C) Orthogonal image representing microglial engulfment of a TUNEL+ cell. (D) The 
number of microglial cells (CD11b-immuoreactive cells) with engulfed TUNEL+ cells (CD11b+/TUNEL+) was 
counted per field, and the results are expressed as the percentage of total microglial cells per field, from 5 to 6 
independent experiments, performed in duplicate. *p<0.05, **p<0.01, ***p<0.001, Kruskall-Wallis test, followed by 
Dunn’s multiple comparison test. Bar: 100 µm. 
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Exposure of primary retinal neural cell cultures to EHP for 4h or 24h significantly 
increased (p<0.001) the number of TUNEL+ cells to 163.4±18.9% and 231.5±26.7% of 
control, respectively. Blockade of A2AR prevented the increase in cell death induced by 
EHP at 4h and 24h to 129.3±14.8% and 143.3±8.9% of control, respectively (Fig. 19A and 
B). Microglia (CD11b+) with TUNEL staining in the nucleus were rarely observed. 
However, we observed that microglial cells had TUNEL staining (Fig. 19C) suggesting that 
microglia are phagocytizing cell debris and apoptotic cells as previously described (Ferrer-
Martin et al., 2014; Jones et al., 1997; Petersen and Dailey, 2004). The number of 
microglia with engulfed TUNEL+ cells was significantly increased upon exposure to EHP 
for 24h (23.7±2.8 cells per field). The treatment with the A2AR antagonist prior exposure 
to EHP for 24h did not significantly change the number of microglia with engulfed dead 
cells (16.2±1.6 cells per field), as compared with control (8.3 ± 2.3 cells per field) (Fig. 
19D). 
 
3.5. Elevated hydrostatic pressure changes microglia morphology 
It is widely accepted that the morphology of microglia changes accordingly to their 
reactive phenotype. Microglial cells were identified with an antibody anti-CD11b and 
several morphological parameters were evaluated. In control conditions microglia cells 
were ramified (Fig. 20A and table 4). Exposure of primary retinal neural cell cultures to 
EHP for 24h significantly decreased the area (Fig. 20B), perimeter (Fig. 20C) and Feret’s 
diameter (Fig. 20D), with a concomitant increase in circularity index (Fig. 20E). In fact, 
EHP significantly diminished microglia area to 53.7±4.5% of control (p<0.01), affecting also 
the perimeter that was significantly decreased to 48.7±7.4% of the control (p<0.001) and 
reducing the Ferret’s diameter significantly to 64.3±5.8% of the control (p<0.01). 
Additionally, microglia circularity index was significantly increased to 0.36±0.05 by EHP 
stimulus (p<0.05) when compared with control conditions (Fig. 20E). Furthermore, the 
blockade of the A2AR partially prevented the effect of EHP by significantly increasing the 
area to 91.4±11.1% of control (p<0.01) when compared to EHP conditions, as well as 
perimeter to 87.1±20.4% of control and Ferret’s diameter that increased to 90.5±7.2% of 
control. Microglial circularity index was not different from control conditions showing the 
partial prevention of A2AR blockade in EHP induced microglia morphology.   
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Table 1 – Morphological parameters in control cells.  
Figure 20 - Elevated hydrostatic pressure changes microglia morphology. Primary mixed retinal cell 
cultures were pre-treated with 50 nM SCH 58261, followed by 1 µg/ml LPS or EHP for 24 hours. Microglial cells 
were identified by immunocytochemistry with anti-CD11b (red). Nuclei were counterstained with DAPI (blue). 
Representative images are depicted in A. Microglia area (B), perimeter (C), Feret’s diameter (D), and circularity 
index (E) were determined using ImageJ. The results are expressed as percentage of control, from 3 to 6 
independent experiments, performed in duplicate. *p<0.05, **p<0.01, ***p<0.001, compared with control; #p<0.05, 
compared with EHP, Kruskall-Wallis test, followed by Dunn’s multiple comparison test. Bar: 100 µm. 
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3.6. Elevated hydrostatic pressure increases the number of 
microglia in primary mixed retinal neural cell cultures 
We observed that the number of microglia in primary retinal neural cell cultures 
exposed to EHP for 24h significantly increased (Fig. 21A and B), suggesting that microglia 
might be proliferating in response to EHP.  
 
In order to assess if the increase in microglia cell number was due to cell 
proliferation, we performed a proliferation assay by incubating the cells with a nuclear 
marker of cell division. Cell cultures were incubated with EdU, an analog of thymidine 
that intercalates in the DNA during S phase (Salic and Mitchison, 2008). Primary retinal 
neural cell cultures were pre-treated with 50 nM SCH 58261 and subjected to EHP for 24 
hours to evaluate the effect of EHP and A2AR blockade in cell proliferation. In control, 
35.5±5.4 cells were stained with EdU, indicating that cells proliferate in control 
conditions. LPS increased the number of the EdU+ cells to 124.8±26.5% of control (Fig. 
22A). 
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Figure 21- Elevated hydrostatic pressure increases the number of microglia in primary mixed retinal 
neural cell cultures. Primary mixed retinal cultures where challenged with EHP for 24 hours. Microglial cells 
were identified by immunocytochemistry with anti-CD11b (red). Nuclei were counterstained with DAPI (blue). 
Representative images are depicted in A. (B) The number of CD11b-immunoreactive per field was counted in 7 
independent experiments, performed in duplicate. **p<0.01, Mann-Whitney test. Bar: 100 µm. 
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In addition, the exposure of primary retinal neural cell cultures to EHP for 24h 
significant increased the number of EDU+ cells to 183.7±32.3% of control (p<0.01). The 
treatment with A2AR antagonist significantly prevented cell proliferation induced by EHP 
(86.2±25.1% of control, p<0.05) (Fig. 22B).  
We also evaluated if microglia cells were proliferating by counting the number of 
proliferating (EdU+) microglia cells (CD11b+) (Fig. 22C). In control conditions only 
11.7±2.6 of the CD11b+ cells were proliferating whereas the exposure to EHP for 24h 
lead to a 3-fold (p<0.01) increase in microglia cell proliferation (31.3±4.7 cells). The 
proliferation of microglia treated with A2AR antagonist following EHP was not different 
from control conditions (17.1±4.1 cells). 
To better clarify the effects of the exposure to EHP in microglia, we used BV-2 cells 
which is a brain derived microglia cell line. 
Figure 22 – A2AR blockade prevents cell proliferation induced by elevated hydrostatic pressure in 
retinal primary mixed retinal cultures. Primary mixed retinal cultures were pre-treated with 50 nM SCH 
58261, followed by 1 µg/ml LPS or EHP for 24 hours. Cell proliferation was measured by counting the number of 
EdU+ cells (green). (A)  Microglial cells were labeled by immunocytochemistry with an antibody anti-CD11b (red). 
Nuclei were counterstained with DAPI (blue) Representative images are depicted. (B) The number of cells stained 
with EdU (EdU+) per field was counted and the results are expressed as percentage of control. (C) The number of 
microglia cells proliferating (EdU+-CD11b-immunoreactive cells) was counted and expressed as the ratio 
EdU+CD11b+/CD11b+, from 5 independent experiments, performed in duplicate. #p<0.05 compared to EHP, 
**p<0.01 compared to control, Kruskall-Wallis test, followed by Dunn’s multiple comparison test. Bar: 100 µm. 
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3.7. Effect of elevated hydrostatic pressure on the levels of pro-
inflammatory cytokines in BV-2 cells  
To assess the effect of the exposure to EHP the release of IL-1β and TNF were 
quantified by ELISA in BV-2 culture medium. In control conditions, the levels of IL-1β 
were 10.1±4.8 pg/ml. As expected, LPS increased the extracellular levels of IL-1β to 
21.6±6.9 pg/ml. Furthermore, when the cells were exposed to EHP for 4 hours or 24 
hours the levels of IL-1β were 31.9±3.0 pg/ml and 28.3±1.6 pg/ml, respectively (Fig. 23A).  
The levels of TNF in control conditions were 17.6±3.8 pg/ml (Fig. 23B). Incubation 
with LPS increased TNF concentration in culture medium to 778.3±118.4 pg/ml. When 
the cells were exposed to EHP for 4h or 24h, TNF levels were 25.8±1.5 pg/ml and 
26.2±3.8 pg/ml, respectively.   
 
 
 
 
3.8. Elevated hydrostatic pressure increases BV-2 cell motility 
In order to evaluate whether EHP changes the motility of microglia cells, BV-2 cell 
cultures were exposed to EHP for 4h. The scratch wound assay (Fig. 24A) was used to 
assess BV-2 cell migration after 4h exposure to EHP. The number of cells in the wound 
significantly increased when the cells were exposed to EHP (49.9±8.9 cells in control vs 
94.4±7.5 cells in EHP; Fig. 24B).  
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Figure 23 - Effect of elevated hydrostatic pressure on the levels of pro-inflammatory cytokines in BV-2 
cells. BV-2 cells were challenged with 100 ng/ml LPS or EHP for 4 or 24 hours. Extracellular levels of IL-1β (A) and TNF 
(B) were quantified by ELISA in cell culture medium supernatants. Results are expressed in pg/ml, from 3 to 5 
independent experiments performed in duplicate. **p<0.01, Kruskall-Wallis test, followed by Dunn’s multiple comparison 
test.  
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Figure 24 - Elevated hydrostatic pressure increases BV-2 cell motility. BV-2 cells migration was assessed 
by scratch wound assay (A) Representative images are depicted for the scratch wound assay: immediately before 
the assay (A1), immediately after the scratch (A2), and at the end of the experiment (A3). (B) The number of cells 
in the wound was counted per field obtained from 5 independent experiments. *p<0.05, compared with control, 
Mann-Whitney test. 
Furthermore, BV-2 cell migration following EHP was assessed using a modified 
Boyden chamber assay. In addition, the effect mediated by the blockade of A2AR was also 
evaluated. 
 
 In control conditions, 33.2 ±11.2 cells per field were counted in the bottom side of 
the transmembrane insert. When the cells were exposed to EHP, the number of cells in 
the bottom side of the transwell significantly increased to 254.7±24.5% of control 
(p<0.01) (Fig. 25A). The effect of EHP in microglia migration was totally prevented by 
A2AR blockade (p<0.05) (Fig. 25B). 
C
o
n
tr
o
l 
4
h
 E
H
P
 
A 
A1 A2 A3 
B 
0
50
100
150
*
Control 4h EHP
C
e
ll
s 
in
 t
h
e
 w
o
u
n
d
(p
e
r
 f
ie
ld
)
Results 
 
53 
 
3.9. Effect of elevated hydrostatic pressure on the extracellular 
levels of ATP and adenosine 
An increase in ATP release has been described as one of the mechanistic alterations 
in neurodegenerative diseases, namely glaucoma (Davalos et al., 2005; Lee, 2013; Reigada 
et al., 2008). In addition, it is known that the sustained augment in adenosine release or 
accumulation is a recognized feature of inflammatory conditions (Hasko et al., 2008). 
Therefore, we evaluated the levels of extracellular ATP and adenosine in BV-2 cell 
cultures exposed to EHP and studied whether A2AR blockade could affect the levels of 
ATP or adenosine when the cells are exposed to EHP. Extracellular levels of ATP were 
quantified by luciferin-luciferase bioluminescence assay in BV-2 cell medium (Fig. 26A). In 
control, conditions the levels of extracellular ATP were 0.59±0.2 pmol/µg of protein. LPS 
increased the extracellular ATP levels to 146.3±28.4% of control. Cultures exposed to 
EHP for 4h or 24h have increased extracellular ATP levels (267.6±82.7% and of 
217.5±57.3% of control, respectively). Interestingly, pre-treatment with A2AR antagonist 
significantly increased the extracellular ATP concentration at both time points studied 
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Figure 25 - A2AR blockade prevented elevated hydrostatic pressure induced BV-2 cell motility. Boyden 
chamber migration assay (A). The number of BV-2 cells in the bottom surface of the transwell was counted.(B) The 
results expressed as percentage of control, from 4 to 5 independent experiments. *p<0.05, **p<0.01, Kruskall-
Wallis test, followed by Dunn’s multiple comparison test. 
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(435.5±68.9% of control and 328.6±117.2% of control, for 4h and 24 h with EHP, 
respectively).  
The levels of extracellular adenosine were quantified by HPLC (Fig. 26B). Adenosine 
levels in control conditions were 0.81±0.17 pmol/µg of protein and increased to 
124.15±13.22% of control and to 131.9±9.6% of control after 4h and 24h exposure to 
EHP, respectively. The pre-treatment with A2AR antagonist did not change adenosine 
levels when the cells were exposed to EHP for 4 hours (124.0±11.3% of control) but 
significantly decreased adenosine concentration at 24 hours (78.2±13.9% of control; 
p<0.05). 
 
3.10. Phagocytosis increases upon elevated hydrostatic pressure in 
BV-2 cells and is prevented by the blockade of A2AR 
The phagocytic efficiency of BV-2 cells was evaluated following exposure to EHP for 
24h. The effect of A2AR blockade in the phagocytosis induced by EHP was also assessed. In 
other to allow the visibility of BV-2 cell engulfment, fluorescent latex beads were 
incubated 1h before the end of the experiment. BV-2 cells where stained with phalloidin 
that binds to F-actin, allowing cell visualization. In control conditions, most of the cells did 
not have beads incorporated (Fig. 27A).  
Incubation with LPS increased the number of beads incorporated and the number of 
cells with beads (Fig. 27A). Exposure to EHP significantly increased phagocytic efficiency 
(22.5±2.4%) when compared with control conditions (p<0.01). Pre-treatment with A2AR 
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Figure 26 – Effect of elevated hydrostatic pressure on the extracellular levels of ATP and adenosine.
BV-2 cells where pre-treated with 50 nM SCH 58261 followed by 100 ng/ml LPS or EHP for 4 hours or 24 hours. 
(A) Extracellular ATP was quantified by luciferin-luciferase bioluminescence assay in cell culture medium. The 
results were normalized to the concentration of protein and are expressed as percentage of control, from 4 to 5 
independent experiments. (B) Extracellular adenosine was quantified by HPLC in cell culture medium supernatant. 
Results were normalized to the amount of protein and are expressed as percentage of control, from 5 to 7 
independent experiments. *p<0.05, compared to control #p<0.01, compared to 24H EHP, Kruskall-Wallis test, 
followed by Dunn’s multiple comparison test. 
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antagonist significantly prevented the increase in phagocytic efficiency induced by EHP 
exposure (p<0.01) (Fig. 27B).  
 
3.11. Effect of elevated hydrostatic pressure on the morphology of 
microglia in retinal organotypic cultures  
To assess the effects of EHP in a more complex model and to investigate the 
potential of the A2AR to modulate these alterations, retinal explants were obtained from 
A2AR-KO mice and wild type mice.   
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Figure 27 - Phagocytic efficiency of BV-2 cell line is increased after exposure to elevated hydrostatic 
pressure and is prevented by the blockade of A2AR. BV-2 cell cultures where pre-treated with 50 nM SCH 
58261 followed by 100 ng/ml LPS or EHP for 24 hours. Phagocytosis was assessed with fluorescent beads. (A) 
Representative images of BV-2 cells stained with phalloidin (red) with incorporated beads (green). Nuclei were 
counterstained with DAPI (blue). (B) Phagocytic efficiency calculated from 4 to 6 independent experiments, 
performed in duplicate. #p<0.05 compared to EHP, **p<0.01 compared to control, Kruskall-Wallis test, followed by 
Dunn’s multiple comparison test. 
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Figure 28 - Retinal structure in WT and KO-A2AR mice. Retinal sections were stained with hematoxylin and 
eosin and the preparations were observed in a light microscope (Leica DM 4000 B). Representative images are 
depicted. 
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Retinal cryosections were stained with hematoxylin and eosin (Fig. 28).  
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Figure 29 – Effect of elevated hydrostatic pressure on the morphology of microglia in retinal 
organotypic cultures. Organotypic retinal cultures were exposed to EHP for 4 or 24 h.  Explants were both 
obtained from wild type and KO-A2AR mice. Microglial cells were identified by immunocytochemistry with anti-Iba-
1 (red). Nuclei were counterstained with DAPI (blue). Representative images are depicted in A. Changes in cell 
morphology were quantified using imageJ according to area (B), perimeter (C), Feret’s diameter (D), and circularity 
(E). Results from 2 independent experiments. Bar: 100 µm. 
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Retinal thickness is similar between wild type and A2AR-KO mice indicating no major 
differences in retinal structure between the two groups. Organotypic retinal cultures 
obtained from wild type and A2AR-KO mice were exposed to EHP for 4h or 24h and 
microglia were stained with an antibody anti Iba-1, We did not observe significant 
alterations in the morphology of microglia after 4h and 24h of EHP (Fig. 29A). Some 
alterations were observed between WT and A2AR-KO mice (Fig. 29B) but these results 
are preliminary (n=2) and therefore we did not assess statistical inference. 
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4. Discussion 
Glaucoma is the second leading cause of visual loss worldwide and is expected that 
by the year 2020 approximately 80 million people will suffer from this disease (Quigley 
and Broman, 2006). Characterized by RGC death and damage to the optic nerve, 
glaucoma is a neurodegenerative disease that leads to progressive and irreversible vision 
loss (Almasieh et al., 2012; Quigley, 1999). The main risk factor for the development of 
glaucoma is elevated IOP. Current treatments are focused on lowering IOP but patients 
continue to lose vision despite IOP control (Cheung et al., 2008). Therefore, new and 
more effective treatments are necessary, and neuroprotection of RGCs is considered to 
offer potential as an alternative therapy (Cordeiro and Levin, 2011). 
Several experimental models have been developed based on elevated IOP, allowing 
the study of the molecular mechanisms underlying glaucomatous alterations. These 
include animal models like retinal ischemia-reperfusion injury (Johnson and Tomarev, 
2010; Selles-Navarro et al., 1996) and obstruction of trabecular meshwork or episcleral 
veins (Almasieh et al., 2012; Urcola et al., 2006) as well as in vitro models in which cells 
are exposed to EHP (Agar et al., 2006; Reigada et al., 2008; Sappington et al., 2006; Zeiss, 
2013). Herein, we studied the role of A2AR on microglia-mediated inflammation triggered 
by EHP, as an in vitro model of elevated IOP. 
Neuroinflammation has been described as an important player in the pathogenesis of 
glaucoma, namely contributing to RGC death (Vohra et al., 2013). Microglia activation has 
an important role in neuroinflammation (Block and Hong, 2005; Lee, 2013), and it may 
contribute for the pathophysiology of glaucoma (Almasieh et al., 2012; Chua et al., 2012; 
Lee, 2013). In retinal neural cell cultures, EHP exposure increased the release of NO. The 
retinal cell culture is composed of neurons, Müller cells, astrocytes and microglia (Alvaro 
et al., 2007; Santiago et al., 2006). All these cells may express iNOS and release NO 
(Farina et al., 2007; Lee, 2013; Newman and Reichenbach, 1996). Nevertheless, in our 
conditions, after EHP, iNOS was detected in microglia, suggesting these cells are the main 
producers of NO upon an increase in EHP. The mechanisms underlying microglia 
activation in glaucomatous optic neuropathy are not clarified yet. Although, in models of 
neurodegenerative diseases, the increased production and release of ROS has been 
described as an early event further triggering microglia activation and release of pro-
inflammatory cytokines (Block and Hong, 2005). In our experimental conditions, EHP 
altered the expression and release of pro-inflammatory mediators in retinal neural cell 
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cultures and in the BV-2 cell line, suggesting that microglia are contributing to the 
inflammatory milieu in these conditions.  
In the resting state, microglia cells are ramified, evenly distributed, and constantly 
surveying the parenchyma. Upon activation, microglia change their morphology becoming 
more amoeboid and less ramified (Kettenmann et al., 2011; Kreutzberg, 1996; Lee, 2013). 
In retinal neural cell cultures, the morphology of microglia, upon exposure to EHP, shifted 
from ramified to more amoeboid, consistent with an activated phenotype.  
Previous studies describe microglia inflammatory responses as being initially 
protective, although sustained and exacerbated responses may ultimately lead to cell loss 
(Karlstetter et al., 2010). The exposure of retinal neural cultures to EHP markedly 
increased cell death. It remains to be clarified whether EHP-induced cell death triggered 
microglia activation or EHP directly elicited a microglia pro-inflammatory response leading 
to cell death. We can not discard the direct impact of EHP on neural cell loss, although 
the experiments performed with the microglia cell line suggest that EHP elicits a pro-
inflammatory response that would potentially damage cells. Nevertheless, EHP per se can 
induce apoptosis in neuronal cell lines (Agar et al., 2006; Agar et al., 2000). One of the 
functions of microglia is to phagocyte damaged cells, cell debris and pathogens 
(Kettenmann et al., 2011; Langmann, 2007; Petersen and Dailey, 2004). We observed a 
clear increase in microglia with engulfed dead cells (TUNEL+ cells), either due to an 
increase in the number of dead cells that needed to be removed or to an increased 
phagocytosis elicited by EHP, as we observed with the BV-2 cell line.  
Microglial cells are also known for promptly migrate to the site of lesion and 
proliferate (Kettenmann et al., 2011). We found that the motility and proliferation of 
microglia increased after exposure to EHP. In addition, cells other than microglia are also 
proliferating. Evidence indicates that astrocytes and Müller cells also play an important 
role in neuroinflammatory responses and that pro-inflammatory mediators highly increase 
their proliferation (Dyer and Cepko, 2000; Farina et al., 2007). Therefore, since these 
cells are also present, we can not rule out their contribution to the inflammatory milieu 
nor as putative proliferating cells. In addition, retinal neuronal progenitor cells have also 
been identified in these cultures (Alvaro et al., 2008) and may also be proliferating 
accounting for the observed results.  
The extracellular levels of ATP increased in BV-2 cells upon exposure to EHP. 
Others have demonstrated that extracellular ATP levels increase in the retina upon 
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pressure elevation (Reigada et al., 2008; Resta et al., 2007). Interestingly, the levels of ATP 
are elevated in the anterior chamber of glaucomatous patients (Li et al., 2011; Zhang et 
al., 2007). The mechanisms by which ATP is released from microglia were not addressed 
in this work, although several mechanisms have been proposed, namely through vesicular 
nucleotide transporter-dependent exocytosis (Imura et al., 2013) and lysosomal 
exocytosis (Dou et al., 2012). In addition, exposure of bovine eyecup preparations to 
elevated pressure increases extracellular ATP levels in which pannexin hemichannels have 
a role (Reigada et al., 2008). In line with the findings of microglial released ATP, it has 
been described that, in activated microglia, ATP induces process retraction leading to a 
more amoeboid morphology and triggering cell migration (Davalos et al., 2005; Gyoneva 
et al., 2009; Imura et al., 2013; Kettenmann et al., 2011), which could explain the 
observed changes in microglia morphology and increased motility induced by EHP.  
Adenosine can be formed extracellularly through ATP catabolism (reviewed in 
(Cunha, 2001) by ectoenzymes (Fredholm et al., 2001). We found an increase in 
extracellular adenosine upon EHP in BV-2 cell line, which is in agreement with the 
increased ATP levels. Microglial cell function is modulated by extracellular adenosine 
through interaction with ARs (Zhong et al., 2013). Activation of A2ARs in microglia has 
been shown to stimulate the proliferation of these cells and to upregulate 
cyclooxygenase-2 expression, resulting in inflammation (Abbracchio and Cattabeni, 1999). 
In addition, the pharmacological blockade or the genetic inactivation of A2AR has been 
described to afford robust neuroprotection against several noxious conditions, namely in 
models of cerebral ischemia, Parkinson’s, Alzheimer’s and Huntington’s diseases (Gomes 
et al., 2011), probably through the control of microglia reactivity (Dare et al., 2007). In 
the retina, A2AR can be detected in INL and GCL, with minor expression in the ONL 
(Kvanta et al., 1997). It is also present in retinal neural cell cultures (Vindeirinho et al., 
2013) In previous studies A2AR expression has been reported to increase in response to 
noxious and inflammatory stimulus (Cunha, 2005; Vindeirinho et al., 2013; Wittendorp et 
al., 2004). Although we were not able to detect changes concerning A2AR expression 
between control and EHP conditions (due to the variability of the results), retinal 
microglial cells express A2AR (Liou et al., 2008) and previous results obtained in our 
laboratory have demonstrated that A2AR density and expression increase upon LPS in 
microglia(Madeira et al., 2012).  
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In our study, we found that the blockade of A2AR prevented the increase in cell death 
induced by EHP. The protective effects of A2AR blockade have been demonstrated 
previously in different models of degenerative diseases (Abbracchio and Cattabeni, 1999; 
Cunha, 2005; Rebola et al., 2011). Furthermore, A2AR blockade decreased EHP-induced 
NO release and iNOS expression and immunoreactivity. In purified retinal microglia cells, 
the blockade of A2AR has been demonstrated to prevent the increase in NO release 
induced by LPS (Madeira et al., 2012), further supporting the contribution microglia to the 
production of NO and the role exerted by A2AR.  
In addition to the effects of A2AR blockade on decreasing EHP-induced cell death, the 
A2AR antagonist also decreased the number of microglia with engulfed dead cells. In line 
with this finding, EHP-induced microglia phagocytosis in BV-2 cells was prevented by A2AR 
blockade. It has already been reported that A2AR blockade prevents LPS-induced microglia 
phagocytosis in purified retinal microglial cell cultures (Madeira et al., 2012). These results 
indicate that either the blockade of A2AR decreases cell death thereby reducing the 
engulfment of dead cells by microglia, or the blockade of the receptor halts microglia 
activation, thus preventing phagocytosis. 
The blockade of A2AR was able to decrease the EHP-induced retraction of microglia 
processes in mixed cultures. The dynamics of microglia processes are under the control 
of A2AR both in physiological and pathological conditions (Orr et al., 2009). Furthermore, 
the treatment with SCH 58261 prevented the EHP-induced microglia cell motility, 
possibly by preventing its activation. Additionally, microglia proliferation induced by EHP 
was clearly reduced by the blockade of A2AR. In fact, blockade of A1R or A2AR has been 
described to prevent microglial cell proliferation (Fiebich et al., 1996; Gebicke-Haerter et 
al., 1996). Interestingly, the blockade of the A2AR was able to decrease the proliferation of 
microglia, but also of other cells. Astrocytes are active players in the inflammatory 
response (Pekny et al., 2014) and the blockade of A2AR has been reported to hamper 
astrogliosis, thus preventing astrocytic proliferation (Dare et al., 2007). Therefore, we  in 
addition to microglia we could relate the decrease in cell proliferation driven by the A2AR 
antagonist, to its modulatory effects in astrocytes. 
The modulation of A2AR activity in ATP and adenosine levels was also assessed. 
Extracellular ATP levels where augmented by the blockade of A2AR. Extracellular ATP is 
known to be very instable being quickly converted into adenosine by Ecto-5’NTs and 
interacting with purinergic receptors (Hasko et al., 2005). Nevertheless, the blockade of 
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the A2AR diminishes the levels of extracellular adenosine suggesting an effect of A2AR in 
adenosine turnover or uptake, possible through the impairment of Ecto-5’NT (CD73) 
activity. In striatal neurons, CD73 has been described to physically interact with A2AR 
(Augusto et al., 2013). CD73 activity is responsible for the formation of adenosine that 
activates A2AR (Augusto et al., 2013). In addition, in synapses the activity of nucleoside 
transporters is controlled by A2AR (Pinto-Duarte et al., 2005). 
Taken together, the effects in BV-2 microglia reactivity can be explained by its 
response to ATP gradients released from damaged cells or in response to EHP 
mechanical stimulus. ATP is promptly converted into adenosine through 
ectonucleotidases and consequently activates A2AR in microglia. Once A2AR is blocked, 
there is a consequent impair in microglia activation and an increase in ATP accumulation 
that apparently is not converted to adenosine.  
The retinal organotypic culture has been described has a suitable model to evaluate 
cellular and molecular signaling mechanisms and to study neuroprotection (Bull et al., 
2011). Therefore this model was used to assess the effects of A2AR genetic knockout 
upon EHP. We did not observe clear differences in microglia morphology after exposure 
to EHP. Nevertheless, previous findings in our laboratory demonstrated changes in 
microglia morphology (to a more amoeboid morphology) in rat retinal explants submitted 
to EHP. One possible explanation for these discrepancies may be that the species (rat or 
mouse) might influence the efficiency of the model and thereby we should consider 
increase the time of exposure and/or the magnitude of pressure. Nevertheless, prior 
studies in mice retinal explants have shown that microglia motility, thereby activation, 
increases upon a noxious insult without significant changes in cell ramification 
(Kettenmann et al., 2011; Lee et al., 2008), demonstrating that evaluation of microglia 
morphology as the single parameter for microglia activation is limited. 
Taken together, the alterations in microglial morphology and in the release of pro-
inflammatory mediators indicate that EHP is triggering microglia activation. These results 
suggest that our experimental model may be a suitable in vitro model to study the 
neuroinflammatory responses of the retina in the context of glaucoma.
 
In addition, our results indicate that the blockade of the A2AR prevents microglia 
reactivity which may attenuate the damage caused by EHP. This may have an impact on 
future studies addressing RGC neuroprotection in the context of glaucoma. 
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5. Concluding remarks and future perspectives 
The results presented in this thesis allow us to conclude that EHP model mimics the 
deleterious effects described in glaucomatous patients and experimental models and the 
blockade of A2AR may prevent neuronal damage by controlling microglia reactivity. In fact 
we were able to demonstrate that:  
• EHP increased oxidative stress in retinal neural cell cultures that was diminished 
by pre-treatment with the A2AR antagonist;  
• Altered the expression and release of pro-inflammatory cytokines in retinal neural 
cell cultures and BV-2 cells was altered upon exposure to EHP. 
• Increased microglia phagocytosis, proliferation and migration that were controlled 
by the blockade of the A2AR; 
• EHP promoted a shift in microglia morphology from ramified to amoeboid which 
was prevented by the blockade of A2AR;  
• Cell death in retinal neural cell cultures increased upon EHP being prevented by 
pre-treatment with the A2AR antagonist;  
• Extracellular of ATP and adenosine levels increased following the exposure to 
EHP.  
 Further experiments will be performed to clarify the role of A2AR on the 
extracellular levels of ATP and adenosine, namely the expression and activity of CD73 
and the transport of adenosine through ENTs. Considering that Müller cells and 
astrocytes have a role in neuroinflammation, we would like also to assess their response 
to EHP and study the effects operated by A2AR blockade.  
Moreover, we will optimize the conditions of EHP in order to compare microglia 
responses in mice retinal organotypic cultures prepared from wild type and A2AR-KO 
animals. 
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